<SEC-DOCUMENT>0001140361-25-000708.txt : 20250110
<SEC-HEADER>0001140361-25-000708.hdr.sgml : 20250110
<ACCEPTANCE-DATETIME>20250110072321
ACCESSION NUMBER:		0001140361-25-000708
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250107
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250110
DATE AS OF CHANGE:		20250110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ATAI Life Sciences N.V.
		CENTRAL INDEX KEY:			0001840904
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40493
		FILM NUMBER:		25520405

	BUSINESS ADDRESS:	
		STREET 1:		WALLSTRASSE 16
		CITY:			BERLIN
		STATE:			2M
		ZIP:			10179
		BUSINESS PHONE:		49 89 2153 9035

	MAIL ADDRESS:	
		STREET 1:		WALLSTRASSE 16
		CITY:			BERLIN
		STATE:			2M
		ZIP:			10179

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ATAI Life Sciences B.V.
		DATE OF NAME CHANGE:	20210115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20040004_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:atai="http://atai.life/20250107" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.12.1.5274
         Copyright 1995 - 2025 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_3860b181bf36435cbbfac6dc40cc9ac4" contextRef="c20250107to20250107" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_6158d46d0163421d8adffc37bcbe83fc" contextRef="c20250107to20250107">0001840904</ix:nonNumeric><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_fb5876eac4474b3eaaeab0a3f3b2edb6" contextRef="c20250107to20250107">00-0000000</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="atai-20250107.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20250107to20250107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840904</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-07</xbrli:startDate><xbrli:endDate>2025-01-07</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div><br/></div>

      <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_d49699ee6bed43a2b007e3a2e70e9bf7" contextRef="c20250107to20250107">8-K</ix:nonNumeric></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
        <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d)</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">of the Securities Exchange Act of 1934</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_53afa4ced35342c99f5e36b2e090ed85" contextRef="c20250107to20250107" format="ixt:date-monthname-day-year-en">January 7, 2025</ix:nonNumeric></div>

      <div><br/></div>

      <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_05cb851f552e4dc38bf41f8c983c9ba5" contextRef="c20250107to20250107">ATAI LIFE SCIENCES N.V.</ix:nonNumeric><br/>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>

      <div><br/></div>

      <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/>
      <div> <br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">The <ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_2811f0ce8b4243fd965af9d4691c810b" contextRef="c20250107to20250107" format="ixt-sec:edgarprovcountryen">Netherlands</ix:nonNumeric> </div>
            </td>

    <td style="width: 34%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_21197cf0332b45358cb2bc538b9bbeed" contextRef="c20250107to20250107">001-40493</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 33%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><span style="-sec-ix-hidden:Fact_fb5876eac4474b3eaaeab0a3f3b2edb6">Not Applicable</span><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(State or other jurisdiction of incorporation or organization)</div>
            </td>

    <td style="width: 34%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(I.R.S. Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_7e20ec09988745c8be237c1ef743c25c" contextRef="c20250107to20250107">Wallstra&#223;e 16</ix:nonNumeric><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_58ccee47255d48d191446d52e3c7d180" contextRef="c20250107to20250107">10179</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_02f10e87f08241b69628fcfd34a0b57e" contextRef="c20250107to20250107">Berlin</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCountry" id="Fact_e018e901511b4557b39a3347a49f54d5" contextRef="c20250107to20250107" format="ixt-sec:countrynameen">Germany</ix:nonNumeric></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Address of principal executive offices) (Zip Code)</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">+<ix:nonNumeric name="dei:CityAreaCode" id="Fact_b263dd54d1c4421a88eb80268a88e465" contextRef="c20250107to20250107">49</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_e2dbb6ba344944729b6173600e671b0a" contextRef="c20250107to20250107">89 2153 9035</ix:nonNumeric></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Registrant&#8217;s telephone number, including area code)</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">N/A</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Former Name or Former Address, if Changed Since Last Report)</div>

      <div style="font-size: 10pt;">
<div><br/></div>

        <hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/> </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
        following provisions:</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_e174097f5bb14b1fa914954aba9747e7" contextRef="c20250107to20250107" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                  </div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_60a92db11d8c425a9a5a5e77e3d26d34" contextRef="c20250107to20250107" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                  </div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_c4b7110b073b4f1bbd0f5fd028de128d" contextRef="c20250107to20250107" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                  </div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
                  </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_b6339c49fd184e9c87be65baae816cee" contextRef="c20250107to20250107" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                  </div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
                  </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Title of each class</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;"><br/>
            </td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Trading</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Symbol(s)</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;"><br/>
            </td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Name of each exchange</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 32%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_5f56ca7809a041818065c93ba9cb8d18" contextRef="c20250107to20250107">Common shares, &#8364;0.10 par value per share</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;"><br/>
            </td>

    <td style="width: 32%; vertical-align: top; font-size: 10pt; text-align: center;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_0c5d8fc3c75c4379836d450a393644ea" contextRef="c20250107to20250107">ATAI</ix:nonNumeric></span><br/>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;"><br/>
            </td>

    <td style="width: 32%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_f8f9c5049f40477383f0c5e9f676c6e9" contextRef="c20250107to20250107" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br/>
              </div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Nasdaq Global Market)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this
        chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_483b590572924a1c9d10ba1d682d6427" contextRef="c20250107to20250107" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
        or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_f865a07d406849fe91035d9a2e66a1ec" contextRef="c20250107to20250107" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
                  Officers.</div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Second Amended and Restated Employment Agreement with Dr. Srinivas Rao</div>

        <div><br/>
        </div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As previously announced in a Current Report on Form 8-K, which was filed by atai Life Sciences N.V. (the &#8220;Company&#8221;) on May 15, 2024, Florian Brand
          stepped down as Co-Chief Executive Officer and member of the Company&#8217;s management board as of December 31, 2024. Dr. Srinivas Rao will serve as the Company&#8217;s sole Chief Executive Officer and principal executive officer, effective January 1, 2025.</div>

        <div><br/>
        </div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On January 8, 2025, Dr. Rao entered into the Second Amended and Restated Employment Agreement with atai Life Sciences US, Inc., a subsidiary of the
          Company (&#8220;ATAI US&#8221;), effective January 1, 2025 (the &#8220;Rao Employment Agreement&#8221;), which Rao Employment Agreement supersedes Dr. Rao&#8217;s prior employment agreement with ATAI US. Pursuant to the Rao Employment Agreement, Dr. Rao is entitled to an
          annual base salary of $629,200, an annual discretionary bonus award targeted at 55% of his then-current base salary and certain tax equalization payments and tax return preparation assistance in the event Dr. Rao receives payments or benefits
          from the Company or ATAI US that become taxable outside of the U.S. solely due to the requirement that Dr. Rao be located outside the U.S. for any period. Pursuant to the Rao Employment Agreement, on January 7, 2025, Dr. Rao was granted an option
          (the &#8220;Option&#8221;) to purchase 2,340,000 common shares of the Company at an exercise price per share equal to the fair market value of the Company&#8217;s common shares on the date of grant. The Option will vest in accordance with the Company&#8217;s standard
          four-year vesting schedule, subject to Dr. Rao&#8217;s continued service through each applicable vesting date. The Rao Employment Agreement further provides that if ATAI US terminates Dr. Rao&#8217;s employment without &#8220;cause&#8221; or he resigns for &#8220;good
          reason,&#8221; subject to his timely executing a release of claims and his continued compliance with certain covenants, he is entitled to receive (i) base salary continuation for a period of 12 months; (ii) payment for any earned but unpaid annual
          bonus for the year prior to the year of termination; and (iii) reimbursement for continued health coverage pursuant to COBRA for up to 12 months following termination. If such a termination of employment occurs on or within 12 months following a
          &#8220;change in control&#8221; (as defined in the Rao Employment Agreement), then, in lieu of the severance payments and benefits described above, subject to his timely executing a release of claims and his continued compliance with certain covenants, Dr.
          Rao is entitled to receive (i) a lump-sum payment equal to 18 months of his annual base salary and 1.5 times his target annual bonus for the year of termination; (ii) payment for any earned but unpaid annual bonus for the year prior to the year
          of termination; (iii) reimbursement for continued health coverage pursuant to COBRA for up to 18 months following termination; and (iv) subject to approval by the supervisory board (the &#8220;Board&#8221;), accelerated vesting of all unvested equity or
          equity-based awards that vest solely based on the passage of time, with any such awards that vest based on the attainment of performance-vesting conditions being governed by the terms of the applicable award agreement, and the time period that
          Dr. Rao may have to exercise any unvested stock options may be extended until the first to occur of (a) 12 months following termination and (b) the expiration of the remaining term of the applicable option.</div>

        <div><br/>
        </div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the Rao Employment Agreement, Dr. Rao has agreed to refrain from soliciting our employees, consultants and clients while employed and
          following his termination of employment for any reason for a period of 12 months.</div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </div>

      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Appointment of Dr. Gerd Kochendoerfer as Chief Operating Officer</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On January 10, 2025, the Company announced that on November 8, 2024, the Board appointed Dr. Gerd Kochendoerfer as the Company&#8217;s Chief Operating Officer,
        effective December 3, 2024. The Company&#8217;s press release announcing Dr. Kochendoerfer&#8217;s appointment and other corporate changes is furnished as Exhibit 99.1 herewith.<br/>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dr. Gerd Kochendoerfer, age 57, previously served as the Chief Operating Officer at NFlection Therapeutics, Inc. (&#8220;NFlection&#8221;), a position he held from
        September 2021 to December 2024. NFlection is a venture-backed biotechnology company focusing on developing targeted therapies to mitigate the aberrant activation of the RAS pathway. In his role, Dr. Kochendoerfer led corporate operations and
        development activities across a broad spectrum of functions.</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Previously, from May 2017 to September 2023, Dr. Kochendoerfer was Senior Vice President and Head of Operations, and a corporate officer, at PellePharm
        Inc. (&#8220;PellePharm&#8221;). At PellePharm, he led development and supply operations for a late-stage orphan oncology program. He was pivotal in the progression of the company&#8217;s lead product, patidegib topical gel, through various development stages and
        regulatory milestones. Dr. Kochendoerfer also contributed to strategic partnerships, financing and acquisition discussions. Before PellePharm, Dr. Kochendoerfer progressed through roles with growing responsibilities, and finally held the position
        of Senior Vice President of Technical Operations at Depomed Inc. (&#8220;Depomed&#8221;) from February 2008 to May 2017. At Depomed, he led multiple clinical development projects that resulted in the approval of five commercial products. Earlier in his career,
        Dr. Kochendoerfer held senior roles at FibroGen, Inc. (&#8220;FibroGen&#8221;), where he was responsible for global project management and FibroGen&#8217;s partnership with Astellas Inc., and at Gryphon Therapeutics, Inc., where he pioneered polymer-modified protein
        therapeutics development. Dr. Kochendoerfer holds a Ph.D. from the University of California, Berkeley and a Diplom degree in Chemistry from Ruprecht-Karls University in Heidelberg, Germany. He is an inventor on multiple patents and the author of
        over 25 peer reviewed publications.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In connection with Dr. Kochendoerfer&#8217;s appointment as the Company&#8217;s Chief Operating Officer, Dr. Kochendoerfer entered into an Executive Employment
        Agreement with ATAI US, dated November 11, 2024 (the &#8220;Kochendoerfer Employment Agreement&#8221;). Pursuant to the Kochendoerfer Employment Agreement, Dr. Kochendoerfer is entitled to an initial annual base salary of $440,000, an annual discretionary
        bonus award targeted at 40% of his then-current base salary and, subject to approval by the Board, an option (the &#8220;Kochendoerfer Option&#8221;) to purchase 1,450,000 common shares of the Company at an exercise price per share equal to the fair market
        value of the Company&#8217;s common shares on the date of grant. The Kochendoerfer Option will vest in accordance with the Company&#8217;s standard four-year vesting schedule, subject to Dr. Kochendoerfer&#8217;s continued service through each applicable vesting
        date. Pursuant to the Kochendoerfer Employment Agreement, Dr. Kochendoerfer is also entitled to a one-time cash sign-on bonus of $75,000, which sign-on bonus is only earned if Dr. Kochendoerfer remains actively employed for a period of one year,
        and is subject to repayment if Dr. Kochendoerfer&#8217;s employment is terminated for &#8220;cause&#8221; or he resigns without &#8220;good reason&#8221; (as these terms are defined in the Kochendoerfer Employment Agreement) within one year of the date he commences employment.
        The Kochendoerfer Employment Agreement further provides that if ATAI US terminates Dr. Kochendoerfer&#8217;s employment without &#8220;cause&#8221; or he resigns for &#8220;good reason,&#8221; subject to his timely executing a release of claims and his continued compliance with
        certain covenants, he is entitled to receive (i) base salary continuation for a period of nine months; (ii) payment for any earned but unpaid annual bonus for the year prior to the year of termination; and (iii) reimbursement for continued health
        coverage pursuant to COBRA for up to nine months following termination. If such a termination of employment occurs on or within 12 months following a &#8220;change in control&#8221; (as defined in the Kochendoerfer Employment Agreement), then, in lieu of the
        severance payments and benefits described above, subject to his timely executing a release of claims and his continued compliance with certain covenants, Dr. Kochendoerfer is entitled to receive (i) a lump-sum payment equal to his annual base
        salary; (ii) payment for any earned but unpaid annual bonus for the year prior to the year of termination; (iii) reimbursement for continued health coverage pursuant to COBRA for up to 12 months following termination; and (iv) subject to approval
        of the Board, accelerated vesting of all unvested equity or equity-based awards that vest solely based on the passage of time, with any such awards that vest based on the attainment of performance-vesting conditions being governed by the terms of
        the applicable award agreement, and the time period that Dr. Kochendoerfer may have to exercise any stock options may be extended for up to 12 months.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

    </div>

    <div>
<div> There are no arrangements or understandings between Dr. Kochendoerfer and any other person pursuant to which Dr. Kochendoerfer was appointed as Chief Operating Officer. Dr. Kochendoerfer has no family relationships subject to disclosure under
      Item 401(d) of Regulation S-K or any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
      </div>
<div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing summaries of the Rao Employment Agreement and the Kochendoerfer Employment Agreement are not complete and each is qualified in its entirety by
          reference to the Rao Employment Agreement and the Kochendoerfer Employment Agreement, filed herewith as Exhibits 10.1 and 10.2, respectively, and each of the Rao Employment Agreement and the Kochendoerfer Employment Agreement is incorporated by
          reference herein.</div>

        <div>&#160;</div>

      </div>

      <div style="font-size: 10pt;">
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 54pt; white-space: nowrap;">
                    <div style="text-align: left; margin-right: 0.25pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Item 7.01</div>
                  </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Regulation FD Disclosure</div>
                  </td>

  </tr>


</table>
          </div>

        </div>

      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On January 10, 2025, the Company issued a press release announcing the appointment of Gerd Kochendoerfer as Chief Operating Officer and other leadership,
        program and corporate updates. A copy of the press release is attached as Exhibit 99.1 and incorporated herein by reference.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The information contained under Item 7.01 of this Form 8-K (including Exhibit 99.1), shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the
        Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange
        Act, except as may be expressly set forth by specific reference in such filing.</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 54pt; white-space: nowrap;">
                <div style="text-align: left; margin-right: 0.25pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Item 9.01.</div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; margin-left: 0.35pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and Exhibits.</div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(d)</div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Exhibits</div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">No.</div>
            </td>

    <td style="width: 1%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>

    <td style="width: 94%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>

    <td colspan="2" style="vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; font-size: 10pt; white-space: nowrap;" rowspan="1"><a href="ef20040004_ex10-1.htm">10.1<br/>
              </a> </td>

    <td style="width: 1%; vertical-align: bottom; font-size: 10pt;" rowspan="1">&#160;</td>

    <td style="width: 94%; vertical-align: top; font-size: 10pt;" rowspan="1">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Employment Agreement between Dr. Srinivas Rao and ATAI Life Sciences US, Inc., dated January 8, 2025.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: left; font-family: 'Times New Roman';"><a href="ef20040004_ex10-2.htm">10.2</a></div>
            </td>

    <td style="width: 1%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>

    <td style="width: 94%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Employment Agreement between Dr. Gerd Kochendoerfer and ATAI Life Sciences US, Inc., dated November 11, 2024.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: left; font-family: 'Times New Roman';"><a href="ef20040004_ex99-1.htm">99.1*</a></div>
            </td>

    <td style="width: 1%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>

    <td style="width: 94%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Press Release, dated January 10, 2025.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">104</div>
            </td>

    <td style="width: 1%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>

    <td style="width: 94%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cover Page Interactive Data File (embedded within the inline XBRL document).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: middle; font-size: 10pt;"><br/>
            </td>

    <td style="width: 1%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>

    <td style="width: 94%; vertical-align: middle; font-size: 10pt;"><br/>
            </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">*</div>
            </td>

    <td style="width: 1%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">&#160;</div>
            </td>

    <td style="width: 94%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Furnished herewith.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
        undersigned hereunto duly authorized.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: bottom; font-size: 10pt;"><br/>
            </td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">ATAI LIFE SCIENCES N.V.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom; font-size: 10pt;"><br/>
            </td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt;"><br/>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Date: January 10, 2025</div>
            </td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
            </td>

    <td style="width: 44.64%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Anne Johnson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom; font-size: 10pt;"><br/>
            </td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Name:</div>
            </td>

    <td style="width: 44.64%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Anne Johnson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom; font-size: 10pt;"><br/>
            </td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Title:</div>
            </td>

    <td style="width: 44.64%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Chief Financial Officer</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    </div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ef20040004_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.12.1.5274
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%--><font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 10.1<br>
        </font></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><img src="image01.jpg"></font></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this &#8220;<font style="font-family: 'Times New Roman';"><u>Agreement</u></font>&#8221;) is made and
        entered into as of the dates next to the signatures below, by and between ATAI Life Sciences US, Inc. a Delaware corporation (the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;) and Srinivas Rao (the &#8220;<font style="font-family: 'Times New Roman';"><u>Executive</u></font>&#8221;). The Company and the Executive may each be referred to in this Agreement individually, as a &#8220;<font style="font-family: 'Times New Roman';"><u>Party</u></font>&#8221; and collectively, as
        the &#8220;<font style="font-family: 'Times New Roman';"><u>Parties</u></font>.&#8221;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; text-indent: 1pt; margin-right: 12.35pt; margin-left: 12.5pt; font-family: 'Times New Roman'; font-size: 10pt;">RECITALS</div>
      <div style="font-size: 10pt;"><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: left; text-indent: 1pt; margin-right: 12.35pt; margin-left: 12.5pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">A.</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The
            Company and Executive previously entered into that certain Employment Agreement, dated as of April 1, 2019, and then subsequently entered into that certain Amended and Restated Employment Agreement, executed in June 2021 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Prior Agreement</u></font>&#8221;).</font></font></div>
      <div style="font-size: 10pt;"><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: left; text-indent: 1pt; margin-right: 12.35pt; margin-left: 12.5pt; font-family: 'Times New Roman'; font-size: 10pt;">B.&#160; &#160; The Company desires to continue to benefit from the services of Executive in the position of Chief
        Executive Officer of the Company and its parent, ATAI Life Sciences N.V. (the &#8220;<font style="font-family: 'Times New Roman';"><u>Parent</u></font>&#8221;), and Executive desires to continue to render such services, on the terms and conditions set forth in
        this Agreement.</div>
      <div style="font-size: 10pt;"><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: left; text-indent: 1pt; margin-right: 12.35pt; margin-left: 12.5pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">C.</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The
            Company desires that Executive perform services through a secondment to Parent (the &#8220;<font style="font-family: 'Times New Roman';"><u>Secondment</u></font>&#8221;) pursuant to the terms of that certain Secondment Letter, dated as of October 17, 2024
            (the &#8220;<font style="font-family: 'Times New Roman';"><u>Secondment Letter</u></font>&#8221;).</font></font></div>
      <div style="font-size: 10pt;"><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: left; text-indent: 1pt; margin-right: 12.35pt; margin-left: 12.5pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">D.</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Effective





            as of January 1, 2025 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Effective Date</u></font>&#8221;), this Agreement will supersede the Prior Agreement in all respects.</font></font></div>
      <div style="font-size: 10pt;"><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">AGREEMENT</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the compensation and benefits provided by the Company and other good and valuable consideration, the receipt and
        sufficiency of which are hereby acknowledged, the Company and the Executive, intending to be legally bound, hereby agree as follows, effective on the Effective Date:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <div>
          <div style="text-indent: 36pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Employment</u></font>. The Company shall continue to employ the Executive, and the Executive shall be employed by the Company, under the terms and conditions set forth in this Agreement.</font></font></div>
        </div>
      </div>
      <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
        </font></div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div>
          <div style="text-indent: 36pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Term</u></font>.&#160; The Executive shall be employed at will, meaning that either the Company or the Executive may terminate the Agreement and the Executive&#8217;s employment at any time for any reason
                or no reason, with or without cause, subject to the terms of this Agreement. The period of Executive&#8217;s employment hereunder is hereinafter referred to as the &#8220;<font style="font-family: 'Times New Roman';"><u>Term</u></font>&#8221;. Executive&#8217;s
                Secondment shall be for the duration set forth in the Secondment Letter, unless terminated earlier by Parent or the Company in their sole discretion, for any reason or no reason. The period of Executive&#8217;s Secondment is hereinafter referred
                to as the &#8220;<font style="font-family: 'Times New Roman';"><u>Secondment Term</u></font>&#8221;.</font></font></div>
        </div>
      </div>
      <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div>
          <div style="text-indent: 36pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Position and Duties</u></font>. The Executive shall have the position of Chief Executive Officer of the Company and Parent,&#160; and shall have the duties and responsibilities commensurate with such
                position, as well as such other duties and responsibilities as the Board of Directors (or equivalent, e.g., the Management Board or Supervisory Board) of the Parent (in either case, the &#8220;<font style="font-family: 'Times New Roman';"><u>Board






                    of Directors</u></font>&#8221; or the &#8220;<font style="font-family: 'Times New Roman';"><u>Board</u></font>&#8221;) may from time-to-time direct to the extent consistent with his position and status as set forth above, including, without limitation,
                providing various services to the Company&#8217;s Affiliates. For purposes of this Agreement, &#8220;<font style="font-family: 'Times New Roman';"><u>Affiliate</u></font>&#8221; means any person in control of, controlled by or under common control with, the
                Company or Parent.</font></font></div>
        </div>
      </div>
      <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
        </font></div>
      <div>
        <div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; text-indent: 36pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Obligations of Executive</u></font><font style="font-size: 10pt;">. The Executive shall devote the Executive&#8217;s services to the Company and shall perform the Executive&#8217;s duties faithfully and to the
              best of the Executive&#8217;s ability. The Executive shall devote the Executive&#8217;s full working time and best efforts to the business and affairs of the Company and Parent and Affiliates and will use his best efforts and business judgment, skill and
              knowledge to the advancement of the Company&#8217;s and Affiliates&#8217; interests and to the discharge of the Executive&#8217;s duties and responsibilities under this Agreement.</font></div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5d37b2f7429b486488ba35b0ff90e864">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(a)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">During the Secondment Term, it is expected that Executive shall spend at least one week per month working from the Parent&#8217;s office in
                  Berlin, Germany, unless otherwise agreed in writing by Parent or the Company, or such additional time as may be reasonably requested by Parent or the Company. Executive shall reasonably cooperate with Parent and the Company with regard to
                  such arrangements to effectuate and maintain conditions and requirements necessary for the Secondment, including with regard to visa requirements, residence registration, and monitoring and addressing correspondence related to Executive&#8217;s
                  presence in Germany. In particular, Executive shall cooperate with the Company and any external visa service provider in order to ensure a smooth and quick application procedure and shall provide without undue delay all necessary
                  documents for visa purposes as requested by the Company and/or any external visa service provider.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1c0aff75346e4e2f84dbba162a83dd2c">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(b)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Executive shall not, at any time during the Term, directly or indirectly, render any business, commercial, or professional services to
                  any other person, firm, or organization (other than the Company and its Affiliates) for compensation without the prior approval of the Board of Directors. Nothing in this Agreement shall preclude the Executive from devoting reasonable
                  periods of time and effort to (a) charitable and community activities; (b) the management of his personal investment assets; or (c) continued provision of existing board advisory services, provided, that in each such case, such activities
                  do not interfere in any material respect with the performance by the Executive of his duties hereunder.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">
        <div>
          <div><font style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Salary and Benefits</u></font>. During the Term, in consideration of the Executive&#8217;s agreement to be employed by the Company and for the services to be rendered under this Agreement, the Company agrees to provide compensation to
                the Executive as follows:</font></font></div>
        </div>
      </div>
      <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
        </font></div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z836b09d753f547988569be2bf844c28d">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(a)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Salary</u></font><font style="font-size: 10pt;">.&#160; During the Term, the
                    Executive shall be paid an annual salary of $629,200 (as may be adjusted from time to time in accordance herewith, the &#8220;<font style="font-family: 'Times New Roman';"><u>Base Salary</u></font>&#8221;) subject to applicable withholdings and
                    deductions and payable in equal semi&#8209;monthly installments or otherwise in accordance with the Company&#8217;s standard payroll cycle. Any increases in the Base Salary shall be determined in the sole discretion of the Board of Directors.</font></div>
              </td>
            </tr>

        </table>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z56b3a0174418436baafd4f73b35da5f8">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(b)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Bonus</u></font><font style="font-size: 10pt;">.&#160; During the Term, the
                    Executive shall be eligible to participate in an annual incentive program established by the Board. Executive&#8217;s annual incentive compensation under such incentive program (the &#8220;<font style="font-family: 'Times New Roman';"><u>Bonus</u></font>&#8221;)








                    shall be targeted at 55% of the Base Salary (the &#8220;<font style="font-family: 'Times New Roman';"><u>Target Bonus</u></font>&#8221;), and subject to applicable withholdings and deductions. The Bonus payable under the incentive program shall be
                    based on the achievement of performance goals to be determined by the Board.&#160; The payment of any Bonus pursuant to the incentive program shall be subject to the approval of the Board of Directors and Executive&#8217;s continued employment
                    with the Company through the applicable date(s) of payment, except as provided in Section 7.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z91aad77beb3e426193a31c438ff1a148">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(c)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref187058427"></a><font style="font-family: 'Times New Roman';"><u>Reimbursement of Expenses</u></font>.&#160; During the Term,
                  the Company shall reimburse the Executive for his reasonable business expenses incurred in the performance of Executive&#8217;s duties under this Agreement in accordance with such policies as the Company may adopt from time to time, and subject
                  to any applicable withholdings and deductions.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z57ea24b5e8304bbea54d85cb1ee4951a">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(d)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Tax Equalization and Tax Preparation</u></font><font style="font-size: 10pt;">. To the extent Executive receives or has received payment or benefits from the Company, the Parent, or any of their subsidiaries, during his employment that become taxable outside of the United States solely due to Executive&#8217;s
                    requirement to be located for any period outside of the United States, including, for the avoidance of doubt, any restricted stock units in Parent granted to Executive on March 14, 2023, but excluding any future grants of restricted
                    stock units, the Company shall provide: (i) tax equalization so that the tax burden incurred by Executive is not greater than the tax that Executive would have paid had Executive not been subject to tax outside the United States (such
                    reimbursements to be paid (net of taxes) within the timeframe required by Treasury Regulation Section 1.409A-1(b)(8)(iii)) for so long as Executive is subject to additional tax solely due to Executive&#8217;s requirement to be located outside
                    of the United States, and (ii) tax return preparation assistance by a mutually agreed firm with such costs to be reimbursed (net of taxes) to Executive to be provided for so long as Executive is receiving such payments or benefits from
                    the Company (including equalization or the tax preparation provided hereunder) but no longer than two years following the date on which Executive ceases to receive any tax equalization payments under this Section.&#160; Notwithstanding the
                    foregoing, such tax equalization shall not apply to any taxes related to Executive&#8217;s exercise of any stock options.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2306b9dc3d754f6090bd53b473886623">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(e)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref69563504"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Benefits</u>.&#160; During the Term, the Executive shall be
                    eligible to participate in employee benefit plans, programs and arrangements, now or hereafter available to employees of the Company, subject to the terms and eligibility requirements thereof and as such plans, programs and arrangements
                    may be amended or in effect from time to time.</font> Additionally, the Company agrees to provide health insurance coverage in Germany for the Executive that meets the minimum requirements for visa purposes. Any additional health
                  insurance coverage beyond the minimum required amount for visa purposes will be provided at the Company&#8217;s sole discretion.</div>
              </td>
            </tr>

        </table>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z910477faed6042a498c4ff98a6f14574">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(f)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Vacation</u></font><font style="font-size: 10pt;">. During the Term, the
                    Executive is allowed to take as much leave as the Executive needs in accordance with Executive&#8217;s manager and the flexible-time off policy of the Company, subject to modification at the Company&#8217;s sole discretion from time to time. Thus,
                    there is no accrued vacation time under this flexible time-off policy to be paid out upon Executive&#8217;s termination for any reason.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zedc7ebcd5a064f82bf703a8210d120fd">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(g)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Sick Leave</u></font><font style="font-size: 10pt;">.&#160; Executive will be
                    eligible for sick time in accordance with Company policy, as modified from time to time in the Company&#8217;s discretion. Currently, US-based employees are eligible to take up to 10 days of paid sick leave per calendar year, with up to ten
                    (10) days carried over to a subsequent year, except as provided by applicable law. Sick leave is not paid out upon termination of employment, unless otherwise required by applicable law.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0adef9194b7e497fa583b527358e1230">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(h)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Equity Grants</u></font><font style="font-size: 10pt;">.&#160; Subject to, and
                    subsequent to, the approval of the Board of Directors, Executive shall be eligible to receive an option to purchase 2,340,000 shares of common stock of the Parent (the &#8220;Options&#8221;). The Options will have an exercise price per share equal
                    to the fair market value of the underlying shares on the date of grant, and will be subject to a four (4) year vesting period with a one (1) year cliff (i.e., 25% vesting upon the first anniversary of the Effective Date and equal
                    monthly vesting over 36 months thereafter, in all cases rounded down for any partial shares and subject in all cases to the Executive&#8217;s continued employment with the Company). For clarity, the Options and grant thereof are expressly
                    subject in all respects to (i) the approval of the Board of Directors, (ii) the Parent&#8217;s equity incentive plan, and (iii) the terms and conditions of the Option agreement(s).</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z78c4621593bd4c1398b1cd31e66d6fff">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(i)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Withholdings</u></font><font style="font-size: 10pt;">. The Company shall,
                    in accordance with applicable law, deduct from the Base Salary and all other amounts payable by the Company under the provisions of this Agreement to the Executive, or, if applicable, to his estate, legal representatives or such other
                    beneficiary designated in writing by the Executive, all social security taxes, all foreign, federal, state and municipal taxes and all other charges and deductions that now or hereafter are required by law to be charged on the
                    compensation of the Executive or charged on cash benefits (&#8220;<font style="font-family: 'Times New Roman';"><u>Tax</u></font>&#8221; or &#8220;<font style="font-family: 'Times New Roman';"><u>Taxes</u></font>&#8221;), irrespective of whether the Company or
                    Parent, or any of their subsidiaries, is required to deduct.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze2a7864a806b490a81917304a8570433">

                <tr>
                  <td style="width: 36pt; font-size: 10pt;">&#160;</td>
                  <td style="width: 27pt; vertical-align: top; text-align: right;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(j)</div>
                  </td>
                  <td style="vertical-align: top;">
                    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indemnification</u></font><font style="font-size: 10pt;">. The
                        Executive shall be eligible for indemnification in accordance with the terms of the Company&#8217;s or any Affiliates&#8217; organizational documents and any indemnification agreements entered into with the Executive, which indemnification
                        shall remain in effect after the Term as it applies to the Executive&#8217;s service to the Company to the same extent it applies to other executives of the Company.</font></div>
                  </td>
                </tr>

            </table>
            <div> <font style="font-size: 10pt;"><br>
              </font> </div>
          </div>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div>
          <div style="text-indent: 36pt;"><font style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;"><u><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">Termination</font></font></u><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></font></div>
        </div>
      </div>
      <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
        </font></div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Executive&#8217;s employment hereunder may be terminated by the Company or Executive, as applicable, without any breach of this Agreement under the
        following circumstances, and the Term will end on the Date of Termination.&#160; &#8220;<font style="font-family: 'Times New Roman';"><u>Date of Termination</u></font>&#8221; shall mean (i) if Executive&#8217;s employment is terminated by reason of Executive&#8217;s death, the
        date of Executive&#8217;s death; or (ii) if Executive&#8217;s employment is terminated pursuant to Section 6(a)(ii)-(vi), either the date indicated in the Notice of Termination or the date specified by the Company pursuant to Section 6(b), whichever is
        earlier.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; font-size: 10pt;"><font style="font-size: 10pt;"><br>
                </font> </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;">
                  <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Circumstances</u></font><font style="font-size: 10pt;">.<font style="font-family: 'Times New Roman'; font-style: italic;">&#160;</font>The Executive shall cease to be an employee of the Company upon the occurrence of any of the following events:</font></div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;"> <font style="font-size: 10pt;"><br>
        </font> </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 81pt; font-size: 10pt;"><font style="font-size: 10pt;"><br>
                  </font> </td>
                <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 12pt;">
                    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman';">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic; font-size: 10pt;">Death.</font><font style="font-size: 10pt;"> Executive&#8217;s employment
                          hereunder shall terminate upon Executive&#8217;s death.</font></div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 81pt; font-size: 10pt;"><font style="font-size: 10pt;"><br>
                  </font> </td>
                <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman';">
                      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref69460459"></a><font style="font-family: 'Times New Roman'; font-style: italic;">Disability</font>.&#160; If Executive has
                        incurred a Disability, as defined below, the Company may terminate Executive&#8217;s employment.</div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 81pt; font-size: 10pt;"><font style="font-size: 10pt;"><br>
                  </font> </td>
                <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(iii) </font></td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref187058865"></a><font style="font-family: 'Times New Roman'; font-style: italic;">Termination for Cause</font>.&#160; The
                      Company may terminate Executive&#8217;s employment for Cause, as defined below.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 81pt; font-size: 10pt;"><font style="font-size: 10pt;"><br>
                  </font> </td>
                <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><font style="font-size: 10pt;">(iv)<br>
                  </font> </td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref187059948"></a><font style="font-family: 'Times New Roman'; font-style: italic;">Termination without Cause</font>.&#160;
                      The Company may terminate Executive&#8217;s employment without Cause.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 81pt; font-size: 10pt;"><font style="font-size: 10pt;"><br>
                  </font> </td>
                <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(v)</font></td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref187060001"></a><font style="font-family: 'Times New Roman'; font-style: italic;">Resignation from the Company with
                        Good Reason</font>.&#160; Executive may resign Executive&#8217;s employment with the Company with Good Reason, as defined below.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 81pt; font-size: 10pt;"><font style="font-size: 10pt;"><br>
                  </font> </td>
                <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(vi)</font></td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
                    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref187058927"></a><font style="font-family: 'Times New Roman'; font-style: italic;">Resignation from the Company without
                        Good Reason</font>.&#160; Executive may resign Executive&#8217;s employment with the Company for any reason other than Good Reason or for no reason.</div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 36pt; font-size: 10pt;">&#160;</td>
                <td style="width: 27pt; vertical-align: top; text-align: right;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(b)</div>
                </td>
                <td style="vertical-align: top;">
                  <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref69460418"></a><font style="font-family: 'Times New Roman';"><u>Notice of Termination</u></font>.&#160; Any termination of
                    Executive&#8217;s employment by the Company or by Executive under this Section 6 (other than termination pursuant to Section 6(a)(i)) shall be communicated by a written notice to the other Party hereto (i) indicating the specific termination
                    provision in this Agreement relied upon, (ii) setting forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive&#8217;s employment under the provision so indicated, if applicable, and (iii)
                    specifying a Date of Termination which, if submitted by Executive, shall be at least three (3) months following the date of such notice (a &#8220;<font style="font-family: 'Times New Roman';"><u>Notice of Termination</u></font>&#8221;); <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that in the event that Executive delivers a Notice of Termination to the
                    Company, the Company may, in its sole discretion, change the Date of Termination to any date that occurs following the date of the Company&#8217;s receipt of such Notice of Termination and is prior to the date specified in such Notice of
                    Termination, but the termination will still be considered a resignation by Executive.&#160; A Notice of Termination submitted by the Company may provide for a Date of Termination on the date Executive receives the Notice of Termination, or
                    any date thereafter elected by the Company.&#160; The failure by either Party to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Cause or Good Reason shall not waive any right of the Party
                    hereunder or preclude the Party from asserting such fact or circumstance in enforcing the Party&#8217;s rights hereunder.</div>
                </td>
              </tr>

          </table>
        </div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcf179f32291f4a1c8e3ce05c7050d1f4">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(c)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref507349729"></a><a name="z_Ref187058527"></a><font style="font-family: 'Times New Roman';"><u>Company Obligations upon
                      Termination</u></font>.&#160; Upon termination of Executive&#8217;s employment pursuant to any of the circumstances listed in this Section 6, Executive (or Executive&#8217;s estate) shall be entitled to receive the sum of:&#160; (i)&#160;the portion of
                  Executive&#8217;s Base Salary earned through the Date of Termination, but not yet paid to Executive; (ii) any expense reimbursements owed to Executive pursuant to Section 5(c); and (iii) any vested benefits owed to Executive under any qualified
                  retirement plan or health and welfare benefit plan in which Executive was a participant in accordance with applicable law and the provisions of such plan.&#160; Except as otherwise expressly required by law (e.g., COBRA) or applicable plan,
                  program, or arrangement or as specifically provided herein, all of Executive&#8217;s rights to salary, severance, benefits, bonuses and other compensatory amounts hereunder (if any) shall cease upon the termination of Executive&#8217;s employment
                  hereunder. In the event that Executive&#8217;s employment is terminated by the Company for any reason, Executive&#8217;s sole and exclusive remedy shall be to receive the payments and benefits described in this Section 6(c) or Section 7, as
                  applicable</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z84c3c34ed2fa4407a859bf2c4fac310f">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(d)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref187058587"></a><font style="font-family: 'Times New Roman';"><u>Deemed Resignation</u></font>.&#160; If the Executive&#8217;s
                  employment with Company terminates for any reason, Executive shall be deemed to have resigned at that time from any and all positions that Executive may have held with Company or Parent or any Affiliates, as designated by Company or
                  Parent or any Affiliates, or any other positions that he held on behalf of Company or Parent or any Affiliates. If, for any reason, this Section 6(d) is deemed insufficient to effectuate such resignation, following a reasonable
                  opportunity to review, Executive hereby authorizes Company and Parent and any Affiliates to execute any documents or instruments consistent herewith which Company may deem necessary or desirable to effectuate such resignation or
                  resignations, and to act as his attorney&#8209;in&#8209;fact. The Company will provide Executive with a copy of such documents.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z022b68f580474a8fb37831ff4b5b1417">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(e)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref69467701"></a><font style="font-family: 'Times New Roman';"><u>Mitigation</u></font>.&#160; The Executive shall not be required
                  to mitigate damages, or the amount of any payment provided for under this Agreement by seeking other employment or otherwise after the termination of his employment hereunder, and any payments earned by the Executive, whether from
                  self&#8209;employment, as a common&#8209;law employee or otherwise, shall not reduce the amount of any amounts under Section 7 otherwise payable to the Executive.&#160; For the avoidance of doubt, this Section 6(e) shall not affect Section 7(b)(ii) or
                  Section 7(c)(ii).</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
        </font></div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z42d908b9337f49728f2e978259d9e239" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 27pt;">
                <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.</font></div>
              </td>
              <td style="text-align: left; vertical-align: top;">
                <div style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Payments upon Termination</u></font>.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z36fa1a9da47a431dacc54d7ad50aca3f">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(a)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination for Cause, or Termination Upon Death, Disability or Resignation
                      from the Company Without Good Reason</u></font><font style="font-size: 10pt;">.&#160; If Executive&#8217;s employment shall terminate as a result of Executive&#8217;s death pursuant to Section 6(a)(i) or Disability pursuant to Section 6(a)(ii),
                    pursuant to Section 6(a)(iii) for Cause, or pursuant to Section 6(a)(vi) for Executive&#8217;s resignation from the Company without Good Reason, then Executive shall not be entitled to any severance payments or benefits, except as provided in
                    Section 6(c).</font></div>
              </td>
            </tr>

        </table>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z02f8b8f6f4954ef7b576b7664a263ad2">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(b)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref69537359"></a><font style="font-family: 'Times New Roman';"><u>Termination without Cause, or Resignation from the Company
                      with Good Reason</u></font>.&#160; If Executive&#8217;s employment is terminated by the Company without Cause pursuant to Section 6(a)(iv), or pursuant to Section 6(a)(v) due to Executive&#8217;s resignation with Good Reason, then except as otherwise
                  provided under Section 7(c) and subject to Executive signing on or before the 21st day (or, in the event of a group termination, the 45th day) following Executive&#8217;s Date of Termination, and not revoking, a release of claims substantially
                  in the form attached as Exhibit A to this Agreement, which form may be updated with any changes as may be reasonably necessary under applicable law to effectuate the intent of the release of claims (the &#8220;Release&#8221;)(and to the extent
                  consent by the Executive is required for such changes, such consent will not be unreasonably withheld), and Executive&#8217;s continued compliance with Section 9, Executive shall receive, in addition to payments and benefits set forth in
                  Section&#160;6(c), the following:</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt; font-size: 10pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; an amount equal to the Executive&#8217;s then-current Base Salary, payable in the form of salary continuation in
              regular installments over the twelve (12) month period following the Date of Termination (the &#8220;<font style="font-family: 'Times New Roman';"><u>Severance Period</u></font>&#8221;) (payable in equal monthly or bi-weekly amounts) in accordance with
              the Company&#8217;s normal payroll practices;</div>
          </div>
        </div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt; font-size: 10pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160; subject to Executive&#8217;s eligibility and election of continuation coverage of group health coverage pursuant to
              COBRA, reimbursement or payment (at Company&#8217;s discretion) of the cost to continue Executive&#8217;s then-current level of group health coverage (including coverage of Executive&#8217;s eligible dependents) during the Severance Period; provided, that such
              reimbursement will cease if Executive receives coverage under a subsequent employer&#8217;s group health plan prior to the end of such Severance Period, notification of which Executive shall provide to Company within three (3) days, and provided,
              further, that, notwithstanding the foregoing, if the Company determines that it cannot provide the benefit required by this clause (b)(ii) without potentially violating applicable law or incurring an excise tax, the Company shall in lieu
              thereof provide to Executive a taxable monthly payment in an amount equal to the monthly COBRA premium that Executive would be required to pay to continue Executive&#8217;s and the Executive&#8217;s covered dependents&#8217; group health coverage in effect on
              the Date of Termination (which amount shall be based on the premium for the first month of COBRA coverage), which payments shall be made regardless of whether Executive elects COBRA continuation coverage and shall commence in the month
              following the month in which the Date of Termination occurs and end on the earliest of (x) the last day of the Severance Period, (y) the date that Executive and/or Executive&#8217;s covered dependents become no longer eligible for COBRA and (z) the
              date Executive becomes eligible to receive healthcare coverage from a subsequent employer (and Executive agrees to promptly notify the Company of such eligibility); and</div>
          </div>
        </div>
        <div><font style="font-size: 10pt;"><br>
          </font> </div>
      </div>
      <div>
        <div>
          <div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt; font-size: 10pt;">(iii)&#160;&#160;&#160;&#160;&#160; the earned but unpaid portion of the Bonus, if any, for any calendar year ending prior to the calendar year in
              which the Date of Termination occurs (as determined by the Board in good faith for the performance year), which amount will be paid no later than April&#160;30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the year in which the Date of Termination occurs.</div>
          </div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1c982d351fb94c15977262d809def2e0">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(c)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Ref69537370"></a><font style="font-family: 'Times New Roman';"><u>Change in Control</u></font>.&#160; In lieu of the payments and
                  benefits set forth in Section 7(b), in the event Executive&#8217;s employment is terminated by the Company without Cause pursuant to Section 6(a)(iv), or pursuant to Section 6(a)(v) due to Executive&#8217;s resignation with Good Reason, in either
                  case, on or within twelve (12) months following the date of a Change in Control, subject to Executive signing on or before the 21st day (or, in the event of a group termination, the 45th day) following Executive&#8217;s Date of Termination, and
                  not revoking, the Release and Executive&#8217;s continued compliance with Section 9, Executive shall receive, in lieu of the payments and benefits set forth in Section 7(b), the following:</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(i)&#160;&#160;&#160;&#160;&#160; &#160;&#160; </font><font style="font-size: 10pt;">an amount in cash equal to the sum of (A) eighteen (18) months of the Executive&#8217;s then-current Base Salary, and (B) 1.5 times the then-current Target Bonus, payable in a lump sum within sixty (60) days following the
              Date of Termination;</font></div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(ii)&#160;&#160;&#160;&#160;&#160; &#160; </font><font style="font-size: 10pt;">the benefits set forth in Section 7(b)(ii), provided that solely for this purpose, &#8220;Severance Period&#8221; shall mean the eighteen (18) month period following the Date of Termination;</font></div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(iii)&#160;&#160;&#160;&#160;&#160; &#160;&#160; </font><font style="font-size: 10pt;">the payment set forth in Section 7(b)(iii); and</font></div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(iv)&#160;&#160;&#160;&#160;&#160; &#160;&#160; </font><font style="font-size: 10pt;">subject to the approval of the Board, all unvested equity or equity-based awards that vest solely based on the passage of time and are then held by the Executive under any Company equity compensation plans shall
              immediately become 100% vested (with any such awards that vest in whole or in part based on the attainment of performance-vesting conditions being governed by the terms of the applicable award agreement), and the time period that the
              Executive may have to exercise any stock options shall be extended for a period equal to the shorter of (x) 12 months or (y) the remaining term of the applicable Option grant.</font></div>
        </div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
                </font> </td>
              <td style="text-align: right; vertical-align: top; width: 27pt;">
                <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">8.</font></div>
              </td>
              <td style="text-align: left; vertical-align: top; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u><font style="font-family: 'Times New Roman';">Certain Definitions</font></u>.</font></td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zac248fff891744be8aa0f2e2ca29aafb">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(a)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cause</u></font><font style="font-size: 10pt;">.&#160; The Company shall have
                    &#8220;Cause&#8221; to terminate Executive&#8217;s employment hereunder upon:</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(i)&#160;&#160;&#160; &#160; &#160;&#160; </font><font style="font-size: 10pt;">the commission by the Executive of, or indictment of the Executive for, (A) a felony or (B) any misdemeanor involving moral turpitude, deceit, or intentional fraud (&#8220;indictment,&#8221; for these purposes, meaning an
              indictment, probable cause hearing or any other procedure pursuant to which an initial determination of probable or reasonable cause with respect to such offense is made);</font></div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(ii)&#160;&#160;&#160; &#160; &#160; </font><font style="font-size: 10pt;">the Executive&#8217;s gross negligence, willful misconduct or repeated insubordination with respect to the Company or any Affiliate;</font></div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(iii)&#160; &#160; &#160;&#160; </font><font style="font-size: 10pt;">the Executive&#8217;s use of alcohol or illegal drugs in a manner that impairs the performance of the Executive&#8217;s obligations under this Agreement;</font></div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(iv)&#160; &#160; &#160;&#160; </font><font style="font-size: 10pt;">the Executive has engaged in misconduct that violates any applicable local, state, federal or foreign law prohibiting workplace harassment, including but not limited to sexual harassment, and/or discrimination, or
              that violates any written policy of the Company or Parent adopted to prevent workplace harassment or discrimination;</font></div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(v)&#160;&#160;&#160;&#160;&#160; &#160;&#160; </font><font style="font-size: 10pt;">the Executive&#8217;s engagement in conduct which the Executive knows or reasonably should have known would cause the Company to violate any local, state, federal or foreign law;</font></div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(vi)&#160;&#160;&#160;&#160; &#160;&#160; </font><font style="font-size: 10pt;">the Executive&#8217;s actions or omissions contribute to the Company facing insolvency, bankruptcy, or similar financial proceedings; or</font></div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(vii)&#160; &#160;&#160; </font><font style="font-size: 10pt;">(A) repeated failure of Executive to substantially perform his employment duties hereunder,&#160; (B) the Executive&#8217;s material breach of any of the material obligations of the Executive under this Agreement if such breach
              is not cured within fifteen (15) days of notice of such breach to the Executive from the Board of Directors, or (C) Company&#8217;s and/or Parent&#8217;s severe financial distress, whereby the Company is in the process of winding down its business and
              Executive&#8217;s employment is terminated in connection with such winding down.</font></div>
        </div>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf4fbe64f949e4028b94754b6c1805afc">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(b)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Change in Control</u></font><font style="font-size: 10pt;">.&#160; &#8220;Change in
                    Control&#8221; shall have the following meaning for purposes of this Agreement:</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(i) &#160; &#160; &#160; &#160;&#160; </font><font style="font-size: 10pt;">any &#8220;person,&#8221; as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Act&#8221;) (other than Parent, any Affiliate, or any trustee, fiduciary or other person or entity
              holding securities under any employee benefit plan or trust of Parent or any Affiliate), together with all &#8220;affiliates&#8221; and &#8220;associates&#8221; (as such terms are defined in Rule 12b-2 under the Act) of such person, shall become the &#8220;beneficial
              owner&#8221; (as such term is defined in Rule 13d-3 under the Act), directly or indirectly, of securities of Parent representing fifty percent (50%) or more of the combined voting power of Parent&#8217;s then outstanding securities having the right to
              vote in an election of the Board of Directors of Parent (&#8220;<font style="font-family: 'Times New Roman';"><u>Voting Securities</u></font>&#8221;) (in such case other than as a result of an acquisition of securities directly from Parent); or</font></div>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div>
        <div>
          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 81pt;"> <font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic; font-size: 10pt;">(ii)&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">the consummation of (A) any consolidation or merger of Parent where the shareholders of Parent, immediately prior to the consolidation or merger, would not, immediately after the consolidation or merger, beneficially
              own (as such term is defined in Rule 13d-3 under the Act), directly or indirectly, shares representing in the aggregate more than fifty percent (50%) of the voting shares of Parent issuing cash or securities in the consolidation or merger (or
              of its ultimate parent corporation, if any), or (B) any sale or other transfer (in one transaction or a series of transactions contemplated or arranged by any party as a single plan) of all or substantially all of the assets of Parent<font style="font-family: 'Times New Roman'; font-style: italic;">.</font></font></div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the foregoing, a Change in Control shall not be deemed to have occurred (x) as a result of a financing transaction involving&#160;
        Parent&#8217;s equity securities, (y) as a result of a transaction that occurs to change the domicile of Parent, or (z) for purposes of the foregoing clause (i) solely as the result of an acquisition of securities by Parent that, by reducing the number
        of shares of Voting Securities outstanding, increases the proportionate number of Voting Securities beneficially owned by any person to fifty percent (50%) or more of the combined voting power of all of the then outstanding Voting Securities;
        provided, however, that if any person referred to in this sentence shall thereafter become the beneficial owner of any additional shares of Voting Securities (other than pursuant to a stock split, stock dividend, or similar transaction or as a
        result of an acquisition of securities directly from Parent) and immediately thereafter beneficially owns fifty percent (50%) or more of the combined voting power of all of the then outstanding Voting Securities, then a Change in Control shall be
        deemed to have occurred for purposes of the foregoing clause (i).&#160; Notwithstanding the foregoing, a Change in Control shall not have occurred unless the transaction or event constituting the Change in Control would also constitute a &#8220;change in
        control event&#8221; (as defined in Treasury Regulation &#167;1.409A-3(i)(5)) under Section 409A (defined below).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0d5d55e091ba4514ac00c8cc89f16074">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(c)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Code</u></font><font style="font-size: 10pt;">.&#160; &#8220;Code&#8221; shall mean the
                    Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z520ba1142db347b2aee5d5bec5f9f159">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(d)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Disability</u></font><font style="font-size: 10pt;">.&#160; &#8220;Disability&#8221; shall
                    mean termination because the Executive is unable due to a physical or mental condition to perform the essential functions of his position with or without reasonable accommodation for nine (9) months in the aggregate during any twelve
                    (12) month period or based on the written certification by two licensed physicians of the likely continuation of such condition for such period.&#160; This definition shall be interpreted and applied consistent with the Americans with
                    Disabilities Act, the Family and Medical Leave Act, and other applicable law.&#160; In the event Executive&#8217;s employment is terminated based on the Executive&#8217;s Disability, then the Executive shall not be entitled to any severance payments or
                    benefits, except as provided in Section 6(c).</font></div>
              </td>
            </tr>

        </table>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z61e4e3c6a39d44ff8d1fd2c825029ac1">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(e)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Good Reason</u>.&#160; &#8220;Good Reason&#8221; shall mean the Company&#8217;s material
                    breach of any of the material obligations of the Company under this Agreement.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Notwithstanding the foregoing, no Good Reason will have occurred unless and until: (a) Executive resigns within ninety (90) days of Executive&#8217;s knowledge of the occurrence of the facts and circumstances underlying the Good Reason
                    event, (b) Executive has provided the Company, within sixty (60) days of Executive&#8217;s knowledge of the occurrence of the facts and circumstances underlying the Good Reason event, written notice stating with specificity the applicable
                    facts and circumstances underlying such finding of Good Reason; (c)&#160;the Company has had an opportunity to cure the same within thirty (30) days after the receipt of such notice; and (d) the Company shall have failed to so cure within
                    such period.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
      </font>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

          <tr style="vertical-align: top;">
            <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="text-align: right; vertical-align: top; width: 27pt;">
              <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">9.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Restrictive Covenants</u></font>.</font></td>
          </tr>

      </table>
      <font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </font>
      <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
        </font></div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7b787bcdeb5c45f98c6d7c48af5dc7f0">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-size: 10pt;">(a)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Confidentiality</u></font><font style="font-size: 10pt;">.&#160; The Parties
                    have previously executed that certain proprietary Confidentiality and Developments Agreement, dated as of April 1, 2019 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Confidentiality and Developments Agreement</u></font>&#8221;),
                    which remains in full force and effect and is hereby made a part of, this Agreement. Upon request by the Company, Executive agrees to execute any subsequent Confidentiality and Developments Agreements as such are updated by Company from
                    time to time.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6a0f2b5ef0714306a73de45601d654df">

            <tr>
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-size: 10pt;">(b)</div>
              </td>
              <td style="vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Nonsolicitation</u></font><font style="font-size: 10pt;">.&#160; During the Term
                    and for a period of twelve (12) months after the Date of Termination, Executive will not directly or indirectly (i) solicit any individual who, at the time of the solicitation is, or within the six (6) month prior to the Date of
                    Termination was, an employee of or consultant to Company or any Affiliate to terminate his or her relationship with the Company or any Affiliate; or (ii) attempt to induce any clients, licensors, licensees or customers of Company or any
                    Affiliate to terminate, breach or materially change any contractual or other relationship with Company or any Affiliate.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-style: italic;"> <br>
        </font></div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="zad9779f054e44ef187ae8cd517547603" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 27pt;">
                <div style="text-align: left; font-style: normal; font-weight: normal; font-size: 10pt;"><font style="font-family: 'Times New Roman';">(c)</font></div>
              </td>
              <td style="text-align: left; vertical-align: top;">
                <div style="font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Use of Material Undisclosed Information</u></font>. The Executive
                    acknowledges that it is the policy of the Company that all employees are prohibited from benefiting from the possession of material undisclosed information concerning the Company or any Affiliates, providers or business partners (in
                    each case provided they are listed on a national or international securities exchange) with respect to trading in the public securities markets. The Executive covenants and agrees that he will abide by such policy.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z7ae6dc5ca9b54da4a27c4bf98cda87ab" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 27pt;">
                <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman';">(d)</font></div>
              </td>
              <td style="text-align: left; vertical-align: top;">
                <div style="font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Reasonable Restrictions</u></font>. The Executive further acknowledges
                    and agrees that the provisions of this Section 9 are reasonable and properly required for the adequate protection of the Company&#8217;s business. Executive represents and warrants that (i)&#160;the restrictive provisions of this Section 9 will
                    not substantially impair Executive&#8217;s ability to earn a livelihood, nor will such provisions cause Executive undue hardship, and (ii) Executive has fully and carefully read this Agreement and has been advised by the Company to consult
                    with an attorney of Executive&#8217;s choice and that Executive fully understands and agrees with the provisions of this Agreement, including this Section 9.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="zfd468e6e6f1946b79dcf8ca7fb913916" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 27pt;">
                <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman';">(e)</font></div>
              </td>
              <td style="text-align: left; vertical-align: top;">
                <div style="font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Blue Penciling</u></font>. If, at the time of enforcement of any of the
                    provisions of this Section 9, a court shall hold that the duration, scope, geographic area or other restrictions stated herein are unreasonable under circumstances then existing, Executive and the Company agree that the maximum
                    duration, scope, geographic area or other restrictions deemed reasonable under such circumstances by such court shall be substituted for the stated duration, scope, geographic area or other restrictions.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
                </font> </td>
              <td style="text-align: right; vertical-align: top; width: 27pt;">
                <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">10.</font></div>
              </td>
              <td style="text-align: justify; vertical-align: top; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Cooperation</u></font>.</font></td>
            </tr>

        </table>
      </div>
      <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
        </font></div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="zfa2a712276d14195ad659309b2f4087d" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 27pt;">
                <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman';">(a)</font></div>
              </td>
              <td style="text-align: left; vertical-align: top;">
                <div style="font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Third&#8209;Party Agreements and Rights</u></font>. The Executive hereby
                    confirms that the Executive is not bound by the terms of any agreement with any previous employer or other party which restricts in any way the Executive&#8217;s use or disclosure of information or the Executive&#8217;s engagement in any business.
                    The Executive represents to the Company that the Executive&#8217;s execution of this Agreement, the Executive&#8217;s continued employment with the Company and the performance of the Executive&#8217;s duties for the Company or any Affiliates will not
                    violate any obligations the Executive may have to any such previous employer or other party. In the Executive&#8217;s work for the Company or any Affiliates, the Executive will not disclose or make use of any information in violation of any
                    agreements with or rights of any such previous employer or other party, and the Executive will not bring to the premises of the Company or any Affiliates any copies or other tangible embodiments of non&#8209;public information belonging to or
                    obtained from any such previous employment or other party.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z5d41dc22bf994be2af0fae0083242e77" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 27pt;">
                <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman';">(b)</font></div>
              </td>
              <td style="text-align: left; vertical-align: top;">
                <div style="font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Litigation and Regulatory Cooperation</u></font>. During and after the
                    Executive&#8217;s employment with the Company, the Executive shall reasonably cooperate with the Company and any Affiliate in the defense or prosecution of any claims or actions now in existence or that may be brought in the future against or
                    on behalf of the Company or any Affiliate that relate to events or occurrences that transpired while the Executive was employed by the Company provided that such cooperation after the termination of Executive&#8217;s employment with the
                    Company does not otherwise interfere with the Executive&#8217;s subsequent employment and/or engagement with a subsequent employer and/or third parties. The Executive&#8217;s reasonable cooperation in connection with such claims or actions shall
                    include, but not be limited to, being available to meet with counsel to prepare for discovery or trial and to act as a witness on behalf of the Company and any Affiliate at mutually convenient times. During and after the Term, the
                    Executive also shall cooperate reasonably with the Company and any Affiliate in connection with any investigation or review of any federal, state or local regulatory authority as any such investigation or review relates to events or
                    occurrences that transpired while the Executive was employed by the Company. The Company or the applicable Affiliate shall reimburse the Executive for any reasonable out&#8209;of&#8209;pocket expenses (including reasonable legal fees) incurred in
                    connection with the Executive&#8217;s performance of obligations pursuant to this Section 10(b).</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="zd168ccbee90c4ff29afa8193b5efa184" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 27pt;">
                <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman';">(c)</font></div>
              </td>
              <td style="text-align: left; vertical-align: top;">
                <div style="font-size: 10pt; text-align: justify;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Injunction</u></font>. The Executive acknowledges that any material
                    breach by Executive of Executive&#8217;s obligations under this Agreement, including but not limited to the restrictions set forth in Section 9 hereof, would result in irreparable injury to the Company or an Affiliate. The Company or the
                    applicable Affiliate shall, therefore, be entitled, without restricting the Company or such applicable Affiliate(s) from other legal and equitable remedies, to injunctive and other equitable relief to prevent or restrain the breach of
                    this Agreement and to withhold compensation and benefits from the Executive if he fails to comply with this Agreement. Nothing in this Section shall be deemed to restrict any other remedy or right the Company, any Affiliate or the
                    Executive may have for any other breach of this Agreement.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="zb2551605b4c142109d2e8d4c952969b0" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 36pt; font-size: 10pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 27pt;">
                <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman';">(d)</font></div>
              </td>
              <td style="text-align: left; vertical-align: top;">
                <div style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Consent to Jurisdiction</u></font>. To the extent that any court action is permitted
                    consistent with or to enforce Section 9 of this Agreement, the Parties hereby consent to the jurisdiction of the State of New York and County of New York. Accordingly, with respect to any such court action, the Executive (a) submits to
                    the personal jurisdiction of such courts; (b) consents to service of process; and (c) waives any other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction or service of process.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">11.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Assignment</u></font>. This Agreement is personal to Executive, and Executive may not assign or delegate any of Executive&#8217;s rights or obligations under this Agreement without first obtaining the written
            consent of the Company. The Company may assign and delegate its rights and obligations under this Agreement, in each case in whole but not in part, without the prior consent of the Executive in the event that, and only in the event that, (a)
            the Company shall effect a reorganization, consolidate with, or merge into, any other corporation, partnership, organization or other entity, or transfer all or substantially all of its properties or assets to any other corporation,
            partnership, organization or other entity, (b) such corporation, partnership, organization or other entity referred to in the preceding clause &#8220;(a)&#8221; including without limitation any affiliate thereof shall by operation of law or expressly in
            writing assume all obligations of the Company hereunder as fully as if it had been originally made a party to this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">12.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Notices</u></font>. All notices required under this Agreement shall be given by personal delivery deemed given on the date of receipt, or by postage prepaid certified or registered mail, return receipt requested, addressed to the
            Company or to the Executive as follows, or to such other address as either Party shall notify the other by like notice:</font></font></div>
      <div style="font-size: 10pt;"><font style="font-size: 10pt;"><br>
        </font> </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z97bb9fbd5b2144628eee4884ed15818a">

          <tr>
            <td style="width: 37.99%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">If to the Company</font><font style="font-size: 10pt;">:</font></div>
            </td>
            <td style="width: 62.01%; vertical-align: middle;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">ATAI Life Sciences US, Inc.<font style="font-family: 'Times New Roman';"><br>
                </font>&#160;c/o Industrious NYC</div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">250 W 34th Street</div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">New York, NY 10019</div>
            </td>
          </tr>
          <tr>
            <td style="width: 37.99%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 62.01%; vertical-align: middle; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 37.99%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 62.01%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">with a copy to (by email)<font style="font-family: 'Times New Roman';"><br>
                </font>Ryan Barrett<font style="font-family: 'Times New Roman';"><br>
                </font>[ <font style="font-family: 'Times New Roman';">&#9679;</font> ]</div>
            </td>
          </tr>
          <tr>
            <td style="width: 37.99%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 62.01%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 37.99%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">If to the Executive</font><font style="font-size: 10pt;">:</font></div>
            </td>
            <td style="width: 62.01%; vertical-align: top;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Srinivas Rao<font style="font-family: 'Times New Roman';"><br>
                </font>[ <font style="font-family: 'Times New Roman';">&#9679;</font> ]</div>
              <div style="font-size: 10pt; margin-left: 9pt;">&#160;</div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">With a copy to [ <font style="font-family: 'Times New Roman';">&#9679;</font>]</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If sent by mail, such notice shall be deemed to have been given on the date of delivery set forth on the registered or certified mail receipt or upon the third (3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup>)
        day after mailing if delivery is refused.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">13.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Expenses of Enforcement</u></font>. In the event that any suit or legal proceeding is brought to enforce any provision of this Agreement, the prevailing Party in such suit or proceeding shall be entitled to
            receive all of such Party&#8217;s reasonable expenses, including reasonable attorneys&#8217; fees and costs, to the fullest extent permitted by law.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">14.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Advice of Counsel</u></font>. The Executive acknowledges that, in executing this Agreement, the Executive has had the opportunity to seek the advice of independent legal counsel, and was individually
            represented by independent legal counsel in negotiating the terms of this Agreement, and has read and understood all of the terms and provisions of this Agreement. This Agreement shall not be construed against any Party by reason of the
            drafting or preparation hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-indent: 36pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">15.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Section 409A</u></font>. This Agreement is intended to comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (&#8220;<font style="font-family: 'Times New Roman';"><u>Section 409A</u></font>&#8221;), and the Parties hereby agree to amend this Agreement as and when necessary or desirable to conform to or otherwise properly reflect any guidance issued under Section 409A after the date hereof without
            violating Section 409A. In case any one or more provisions of this Agreement fails to comply with the provisions of Section 409A, the remaining provisions of this Agreement shall remain in effect, and this Agreement shall be administered and
            applied as if the non-complying provisions were not part of this Agreement. The Parties in that event shall endeavor to agree upon a reasonable substitute for the non-complying provisions, to the extent that a substituted provision would not
            cause this Agreement to fail to comply with Section 409A, and, upon so agreeing, shall incorporate such substituted provisions into this Agreement. A termination of the Executive&#8217;s employment hereunder shall not be deemed to have occurred for
            purposes of any provision of this Agreement providing for the payment of any amount or benefit constituting &#8220;deferred compensation&#8221; under Section 409A upon or following a termination of employment unless such termination is also a &#8220;separation
            from service&#8221; within the meaning of Section 409A and, for purposes of any such provision of this Agreement, references to a &#8220;termination,&#8221; &#8220;termination of employment&#8221; or like terms shall mean &#8220;separation from service.&#8221; In the event that any
            payment or benefit made hereunder or under any compensation plan, program or arrangement of the Company would constitute payments or benefits pursuant to a non-qualified deferred compensation plan within the meaning of Section 409A and, at the
            time of the Executive&#8217;s &#8220;separation from service&#8221; the Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A, then any such payments or benefits shall be delayed until the six-month anniversary of the date of Executive&#8217;s
            &#8220;separation from service&#8221;. Each payment made under this Agreement shall be designated as a &#8220;separate payment&#8221; within the meaning of Section 409A. All reimbursements and in-kind benefits provided under this Agreement shall be made or provided in
            accordance with the requirements of Section 409A to the extent that such reimbursements or in-kind benefits are subject to Section 409A. All reimbursements for expenses paid pursuant hereto that constitute taxable income to the Executive shall
            in no event be paid later than the end of the calendar year next following the calendar year in which the Executive incurs such expense or pays such related tax. Unless otherwise permitted by Section 409A, the right to reimbursement or in-kind
            benefits under this Agreement shall not be subject to liquidation or exchange for another benefit and the amount of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses
            eligible for reimbursement, or in-kind benefits to be provided, respectively, in any other taxable year.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">16.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Section 280G</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zac7b32d2d0ba42ed95997eda046c5614">

            <tr>
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(a)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding anything contained in this Agreement to the contrary, in the event that any payment or benefit received or to be
                  received by the Executive (whether pursuant to the terms of this Agreement or any other plan, arrangement or agreement) (all such payments and benefits being hereinafter referred to as the &#8220;<font style="font-family: 'Times New Roman';"><u>Total






                      Payments</u></font>&#8221;) would be subject (in whole or part), to the excise tax imposed under Section 4999 of the Code (the &#8220;<font style="font-family: 'Times New Roman';"><u>Excise Tax</u></font>&#8221;), then, after taking into account any
                  reduction in the Total Payments provided by reason of Section 280G of the Code in any other plan, arrangement or agreement, then such remaining Total Payments shall be reduced, to the extent necessary so that no portion of the Total
                  Payments is subject to the Excise Tax but only if (i) the net amount of such Total Payments, as so reduced (and after subtracting the net amount of federal, state and local income taxes on such reduced Total Payments and after taking into
                  account the phase out of itemized deductions and personal exemptions attributable to such reduced Total Payments) is greater than or equal to (ii) the net amount of such Total Payments without such reduction (but after subtracting the net
                  amount of federal, state and local income taxes on such Total Payments and the amount of Excise Tax to which Executive would be subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized
                  deductions and personal exemptions attributable to such unreduced Total Payments).</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z86506a742428443c80b689d4ef42134e">

            <tr>
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(b)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For purposes of determining whether and the extent to which the Total Payments will be subject to the Excise Tax, (i) no portion of the
                  Total Payments the receipt or enjoyment of which Executive shall have waived at such time and in such manner as not to constitute a &#8220;payment&#8221; within the meaning of Section 280G(b) of the Code shall be taken into account; (ii) no portion
                  of the Total Payments shall be taken into account which, in the written opinion of an independent, nationally recognized accounting firm (the &#8220;<font style="font-family: 'Times New Roman';"><u>Independent Advisors</u></font>&#8221;) selected by
                  the Company, does not constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G(b)(2) of the Code (including by reason of Section 280G(b)(4)(A) of the Code) and, in calculating the Excise Tax, no portion of such Total Payments
                  shall be taken into account which, in the opinion of Independent Advisors, constitutes reasonable compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the &#8220;base amount&#8221; (as
                  defined in Section 280G(b)(3) of the Code) allocable to such reasonable compensation; and (iii) the value of any non-cash benefit or any deferred payment or benefit included in the Total Payments shall be determined by the Independent
                  Advisors in accordance with the principles of Sections 280G(d)(3) and (4) of the Code.</div>
              </td>
            </tr>

        </table>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">17.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Miscellaneous</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0674697acd844fd899be76486355f3ff">

            <tr>
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(a)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">This Agreement shall be governed by, and construed exclusively in accordance with, the laws of the State of New York without giving
                  effect to any choice or conflict of law rules to the contrary. Each Party submits to the nonexclusive jurisdiction of any United States District Court located in New York, New York and of any New York state court sitting in New York, New
                  York for purposes of all legal proceedings arising out of or relating to this Agreement or the transactions contemplated hereby. Each Party irrevocably waives any objection which it may now or hereafter have to the laying of venue in any
                  proceeding brought in such a court, and any claim that any such proceeding was brought in an inconvenient forum.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z05f625fb751c4c4baf64adfb6658bfb1">

            <tr>
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(b)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Should any provision of this Agreement be held invalid or unenforceable, the remainder of this Agreement shall not be affected and shall
                  be enforceable to the fullest extent permitted at law or in equity.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9f5962cd3f914f88b5977b5662987f16">

            <tr>
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(c)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">This Agreement (together with the Exhibits hereto, if any) contains the entire agreement between the Parties concerning the subject
                  matter hereof and supersedes all prior conversations, proposals, negotiations, understandings and agreements, whether written or oral, concerning the subject matter hereof, including, without limitation, the Prior Agreement.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z43b50133f697463b997886f2a0796c5c">

            <tr>
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(d)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">This Agreement shall not be amended, altered, changed, modified, supplemented or rescinded in any manner except by written agreement
                  executed by both Parties expressly referring to this Agreement.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z36db17ec576b41cb9b2a8ec25f00c9db">

            <tr>
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(e)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving Party. The failure of any Party to
                  require the performance of any term or obligation of this Agreement, or the waiver by any Party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any
                  subsequent breach.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf9697aaa5746422294482f96485e7b67">

            <tr>
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(f)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be an
                  original; but such counterparts shall together constitute one and the same document.</div>
              </td>
            </tr>

        </table>
        <div> <font style="font-size: 10pt;"><br>
          </font> </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8363d8e5ef6242078da61d06273c96f5">

            <tr>
              <td style="width: 36pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; text-align: right; font-size: 10pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(g)</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Parties recognize that litigation in federal or state courts or before federal or state administrative agencies of disputes arising
                  out of the Executive&#8217;s employment with the Company or out of this Agreement, or the Executive&#8217;s termination of employment or termination of this Agreement, or the Restrictive Covenants, may not be in the best interests of either the
                  Executive or the Company, and may result in unnecessary costs, delays, complexities, and uncertainty. The Parties agree that any dispute between the Parties arising out of or relating to the negotiation, execution, performance or
                  termination of this Agreement or the Executive&#8217;s employment, including, but not limited to, any claim arising out of this Agreement, claims under Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1991, the Age
                  Discrimination in Employment Act of 1967, the Americans with Disabilities Act of 1990, Section 1981 of the Civil Rights Act of 1966, as amended, the Family Medical Leave Act, the Executive Retirement Income Security Act, and any similar
                  federal, state or local law, statute, regulation, or any common law doctrine, whether that dispute arises during or after employment, shall be settled by binding arbitration in accordance with the National Rules for the Resolution of
                  Employment Disputes of the American Arbitration Association (the rules can be found at https;//www.adr.org/sites/default/files/EmploymentRules_Web.pdf/, or a copy will be provided upon request); <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>,<font style="font-family: 'Times New Roman'; font-style: italic;"> however</font>,<font style="font-family: 'Times New Roman'; font-style: italic;">&#160;</font>that this dispute resolution
                  provision shall not apply to any separate agreements between the Parties that do not themselves specify arbitration as an exclusive remedy. The location for the arbitration shall be the New York metropolitan area. Any award made by such
                  panel shall be final, binding and conclusive on the Parties for all purposes, and judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof. The arbitrators&#8217; fees and expenses and all
                  administrative fees and expenses associated with the filing of the arbitration shall be borne by the Company; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>,<font style="font-family: 'Times New Roman'; font-style: italic;"> however</font>, that at the Executive&#8217;s option, Executive may voluntarily pay up to one&#8209;half the costs and fees. The Parties acknowledge and agree that their obligations to arbitrate under this Section survive the
                  termination of this Agreement and continue after the termination of the employment relationship between Executive and the Company. The Parties each further agree that the arbitration provisions of this Agreement shall provide each Party
                  with its exclusive remedy, and each Party expressly waives any right it might have to seek redress in any other forum, except as otherwise expressly provided in this Agreement. By election of arbitration as the means for final settlement
                  of all claims, <font style="font-family: 'Times New Roman'; font-weight: bold;">the Parties hereby waive their respective rights to, and agree not to, sue each other in any action in a Federal, State or local court with respect to such
                    claims, but may seek to enforce in court an arbitration award rendered pursuant to this Agreement. The Parties specifically agree to waive their respective rights to a trial by jury, and further agree that no demand, request or motion
                    will be made for trial by jury. Except as may be prohibited by applicable law, the foregoing waiver includes the ability to assert claims as a plaintiff or class member in any purported class or representative proceeding.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;"><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">[Signature page to follow]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Parties have duly executed this Agreement as of the date set forth opposite their respective names below.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2dd77898b2454526b41d26c7e81ee2de">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">COMPANY</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1" rowspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ATAI LIFE SCIENCES N.V.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1" rowspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2"><font style="font-size: 10pt;"><br>
              </font> </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Ryan Barrett<br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Name: Ryan Barrett<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Title: General Counsel and Lead of Corp Dev<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1" rowspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Date: 08 January 2025<br>
              </div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><font style="font-size: 10pt;"><br>
        </font> </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z71af647d42bb4a2d9e66c35518e5962e">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="2" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ATAI LIFE SCIENCES US, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="2" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Ryan Barrett </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Name: Ryan Barrett</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Title: General Counsel and Lead of Corp Dev</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1" rowspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Date: 08 January 2025</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: 400;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td colspan="2" style="vertical-align: top; font-size: 10pt;" rowspan="1">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXECUTIVE</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
              <td colspan="2" style="vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1"><font style="font-size: 10pt;">/s/ </font>Srinivas Rao </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td colspan="2" style="vertical-align: top; font-size: 10pt;" rowspan="1">Srinivas Rao</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
              <td colspan="2" style="vertical-align: top; font-size: 10pt;" rowspan="1"><font style="font-size: 10pt;"><br>
                </font> </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 3%; vertical-align: top; font-size: 10pt;" rowspan="1">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br>
                </div>
              </td>
              <td style="width: 47%; vertical-align: top; font-size: 10pt;" rowspan="1">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Date: 08 January 2025</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: left; margin-left: 216pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <!--PROfilePageNumberReset%Num%1%%%-->
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>EXHIBIT A</u></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Separation Agreement and Release</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Separation Agreement and Release (&#8220;<font style="font-family: 'Times New Roman';"><u>Agreement</u></font>&#8221;) is made by and between Srinivas Rao (&#8220;<font style="font-family: 'Times New Roman';"><u>Executive</u></font>&#8221;) and ATAI Life Sciences US, Inc., a Delaware corporation (together with any successor, the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;) (collectively
        referred to as the &#8220;<font style="font-family: 'Times New Roman';"><u>Parties</u></font>&#8221; or individually referred to as a &#8220;<font style="font-family: 'Times New Roman';"><u>Party</u></font>&#8221;).&#160; Capitalized terms used but not defined in this
        Agreement shall have the meanings set forth in the Employment Agreement (as defined below).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the Parties have previously entered into that certain Second Amended and Restated Employment Agreement, dated as of _____, 20__ (the &#8220;<font style="font-family: 'Times New Roman';"><u>Employment Agreement</u></font>&#8221;); and</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, in connection with Executive&#8217;s termination of employment with the Company or a subsidiary or affiliate of the Company effective ________,
        20__, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that Executive may have against the Company and any of the Releasees as defined below, including, but not limited to,
        any and all claims arising out of or in any way related to Executive&#8217;s employment with or separation from the Company or its subsidiaries or affiliates but, for the avoidance of doubt, nothing herein will be deemed to release any rights or remedies
        in connection with Executive&#8217;s ownership of vested equity securities of the Company or one if its affiliates, vested benefits or Executive&#8217;s right to indemnification by the Company or any of its affiliates pursuant to contract or applicable law
        (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Retained Claims</u></font>&#8221;).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the severance payments and benefits described in Section [7(b)/7(c)] of the Employment Agreement, which, pursuant
        to the Employment Agreement, are conditioned on Executive&#8217;s execution and non-revocation of this Agreement, and in consideration of the mutual promises made herein, the Company and Executive hereby agree as follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Severance Payments and Benefits; Salary and Benefits</u></font>.&#160; The Company agrees to provide Executive with the severance payments and benefits described in Section [7(b)/7(c)] of the Employment Agreement, payable at the times
            set forth in, and subject to the terms and conditions of, the Employment Agreement. In addition, to the extent not already paid, and subject to the terms and conditions of the Employment Agreement, the Company shall pay or provide to Executive
            all other payments or benefits described in Section 6(c) of the Employment Agreement, subject to and in accordance with the terms thereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Release of Claims</u></font>.&#160; Executive agrees that, other than with respect to the Retained Claims, the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by the Company, any
            of its direct or indirect subsidiaries and affiliates, and any of its or their current and former officers, directors, equityholders, managers, employees, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans,
            plan administrators, insurers, trustees, divisions, and subsidiaries and predecessor and successor corporations and assigns (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Releasees</u></font>&#8221;).&#160; Executive, on Executive&#8217;s
            own behalf and on behalf of any of Executive&#8217;s affiliated companies or entities and any of their respective heirs, family members, executors, agents, and assigns, other than with respect to the Retained Claims, hereby and forever releases the
            Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, or cause of action relating to any matters of any kind, whether presently known or unknown,
            suspected or unsuspected, that Executive may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the date Executive signs this Agreement, including, without
            limitation:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 63pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any and all claims relating to or arising
            from Executive&#8217;s employment or service relationship with the Company or any of its direct or indirect subsidiaries or affiliates and the termination of that relationship;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div style="text-align: left; text-indent: 63pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any and all claims relating to, or arising
            from, Executive&#8217;s right to purchase, or actual purchase of any shares of stock or other equity interests of the Company or any of its affiliates, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty,
            breach of duty under applicable state law, and securities fraud under any state or federal law;</font></font></div>
      <div style="font-size: 10pt; text-indent: 63pt;">&#160;</div>
      <div style="text-align: left; text-indent: 63pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any and all claims for wrongful discharge of
            employment; termination in violation of public policy; discrimination; harassment; retaliation; breach of contract, both express and implied; breach of covenant of good faith and fair dealing, both express and implied; promissory estoppel;
            negligent or intentional infliction of emotional distress; fraud; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel;
            slander; negligence; personal injury; assault; battery; invasion of privacy; false imprisonment; conversion; and disability benefits;</font></font></div>
      <div style="font-size: 10pt; text-indent: 63pt;">&#160;</div>
      <div style="text-align: left; text-indent: 63pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">denial of protection or benefits under any
            and all claims for violation of any federal, state, or municipal statute, ordinance, executive order, regulation, including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Rehabilitation Act of
            1973; the Americans with Disabilities Act of 1990; the Equal Pay Act; the Fair Labor Standards Act; the Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967; the Older Workers Benefit Protection Act; the Employee
            Retirement Income Security Act of 1974; the Worker Adjustment and Retraining Notification Act; the Family and Medical Leave Act; and the Sarbanes-Oxley Act of 2002, each as amended, and any other foreign, federal, state or local statute,
            ordinance, executive order, regulation or constitution regarding employment, termination of employment, discrimination, harassment, retaliation, health and safety, privacy, notice, or wage and hour matters;</font></font></div>
      <div style="font-size: 10pt; text-indent: 63pt;">&#160;</div>
      <div style="text-align: left; text-indent: 63pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any and all claims for violation of the
            federal or any state constitution;</font></font></div>
      <div style="font-size: 10pt; text-indent: 63pt;">&#160;</div>
      <div style="text-align: left; text-indent: 63pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any and all claims arising out of any other
            laws and regulations relating to employment or discrimination, harassment, or retaliation on the basis of any characteristic protected under the law, including but not limited to race, color, national origin, sex, pregnancy, sexual orientation,
            gender identity, religion, disability, marital or parental status, age, union activity or other protected activity;</font></font></div>
      <div style="font-size: 10pt; text-indent: 63pt;">&#160;</div>
      <div style="text-align: left; text-indent: 63pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any claim for any loss, cost, damage, or
            expense arising out of any dispute over the non-withholding or other tax treatment of any of the proceeds received by Executive as a result of this Agreement;</font></font></div>
      <div style="font-size: 10pt; text-indent: 63pt;">&#160;</div>
      <div style="text-align: left; text-indent: 63pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any and all claims arising out of the wage
            and hour and wage payments laws and regulations of the state or states in which Executive has provided service to the Company or any of its affiliates (including without limitation the California Labor Code and New York Labor Law (including but
            not limited to all provisions prohibiting discrimination and retaliation, and all provisions regulating wage and hour law); and</font></font></div>
      <div style="font-size: 10pt; text-indent: 63pt;">&#160;</div>
      <div style="text-align: left; text-indent: 63pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any and all claims for attorneys&#8217; fees and
            costs.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released.
        Executive acknowledges that Executive has been advised of and is familiar with the provisions of laws that may prohibit the release of unknown claims, including for example California Civil Code Section 1542, which states:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER
        FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.</div>
      <div style="font-size: 10pt;"><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Executive, being aware of said code section, expressly waives all rights Executive may have thereunder, if applicable, as well as under any other statute or common law
        principles of similar effect. Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released.&#160; This release does not release claims that cannot be
        released as a matter of law, including, but not limited to, Executive&#8217;s right to report possible violations of federal law or regulation to any governmental agency or entity in accordance with the provisions of and rules promulgated under Section
        21F of the Securities Exchange Act of 1934 or Section 806 of the Sarbanes-Oxley Act of 2002, or any other whistleblower protection provisions of state or federal law or regulation and any right to receive an award for information provided
        thereunder, Executive&#8217;s right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission, or any other local, state, or federal administrative body or government agency that is authorized to enforce or
        administer laws related to employment, against the Company for discrimination (with the understanding that Executive&#8217;s release of claims herein bars Executive from recovering such monetary relief from the Company or any Releasee for any alleged
        discriminatory treatment), claims for unemployment compensation or any state disability insurance benefits pursuant to the terms of applicable state law, claims to continued participation in certain of the Company&#8217;s group benefit plans pursuant to
        the terms and conditions of COBRA, claims to any benefit entitlements vested as the date of separation of Executive&#8217;s employment, pursuant to written terms of any employee benefit plan of the Company or its affiliates and Executive&#8217;s right under
        applicable law and any Retained Claims.&#160; This release further does not release claims for breach of Section 6(c) or Section [7(b)/7(c)] of the Employment Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Acknowledgment of Waiver of Claims under ADEA</u></font>.&#160; Executive understands and acknowledges that Executive is waiving and releasing any rights Executive may have under the Age Discrimination in Employment Act of 1967 (&#8220;<font style="font-family: 'Times New Roman';"><u>ADEA</u></font>&#8221;), and that this waiver and release is knowing and voluntary.&#160; Executive understands and agrees that this waiver and release does not apply to any rights or claims that may arise
            under the ADEA after the date Executive signs this Agreement.&#160; Executive understands and acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled.&#160;
            Executive further understands and acknowledges that Executive has been advised by this writing that:&#160; (a) Executive should consult with an attorney prior to executing this Agreement; (b) Executive has 21 days within which to consider this
            Agreement, (provided, however, that in the event of Executive&#8217;s separation as part of a group reduction in force, he shall have forty-five (45) days within which to consider this Agreement), and the Parties agree that such time period to review
            this Agreement shall not be extended upon any material or immaterial changes to this Agreement; (c) Executive has seven business days following Executive&#8217;s execution of this Agreement to revoke this Agreement pursuant to written notice to the
            Company; (d) this Agreement shall not be effective until after the revocation period has expired; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of
            this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law.&#160; In the event Executive signs this Agreement and returns it to the Company in less than the
            21 (or 45) day period identified above, Executive hereby acknowledges that Executive has freely and voluntarily chosen to waive the time period allotted for considering this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Severability</u></font>.&#160; In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be
            illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision or portion of provision.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: right;"><img src="image01.jpg"></div>
          </div>
        </div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>No Oral Modification</u></font>.&#160; This Agreement may only be amended in a writing signed by Executive and a duly authorized officer of the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Governing Law; Dispute Resolution</u></font>.&#160; This Agreement shall be subject to the provisions of Section 12 and Section 17(a) and (g) of the Employment Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Effective Date</u></font>.&#160; Executive has seven business days after Executive signs this Agreement to revoke it and this Agreement will become effective on the day immediately following the seventh business day after Executive
            signed this Agreement, so long as it has been signed by the Parties and has not been revoked by Executive before that date.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">8.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Voluntary Execution of Agreement</u></font>.&#160; Executive understands and agrees that Executive executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with
            the full intent of releasing all of Executive&#8217;s claims against the Company and any of the other Releasees.&#160; Executive acknowledges that:&#160; (a) Executive has read this Agreement; (b) Executive has not relied upon any representations or statements
            made by the Company that are not specifically set forth in this Agreement; (c) Executive has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of Executive&#8217;s own choice or has elected not to
            retain legal counsel; (d) Executive understands the terms and consequences of this Agreement and of the releases it contains; (e) Executive is fully aware of the legal and binding effect of this Agreement; and (f) Executive has had 21 (or 45)
            days to review this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z25e2d8cceb3346fa995733fcbb853866">

          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">EXECUTIVE</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; padding-bottom: 2px; font-size: 10pt;" rowspan="1" colspan="3">&#160;</td>
            <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1" colspan="2">&#160;</td>
            <td style="width: 22%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Dated:</font><font style="font-size: 10pt;"> <br>
                </font></div>
            </td>
            <td style="width: 10%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 20%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
            <td style="vertical-align: top; padding-bottom: 2px;" colspan="3">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Srinivas Rao</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" rowspan="1" colspan="3">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt;" rowspan="1" colspan="3">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">ATAI LIFE SCIENCES US, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" rowspan="1" colspan="3">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt;" rowspan="1" colspan="3">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt; padding-bottom: 2px;" rowspan="1" colspan="3">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt; padding-bottom: 2px; width: 3%;" rowspan="1"><font style="font-family: 'Times New Roman';">By:</font></td>
            <td style="vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0); width: 42%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt; padding-bottom: 2px; width: 22%;" rowspan="1">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Dated:</font><font style="font-size: 10pt;"> <br>
                </font></div>
            </td>
            <td style="width: 10%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 22%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
            <td style="vertical-align: top; width: 65%; padding-bottom: 2px;">
              <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman';">Name:<font style="font-family: 'Times New Roman';"><br>
                  </font></font></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" rowspan="1" colspan="3">&#160;</td>
            <td style="vertical-align: top; width: 65%; font-size: 10pt;" rowspan="1"><font style="font-family: 'Times New Roman';">Title:</font></td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="font-size: 10pt;"><font style="font-size: 10pt;">&#160;</font>
        <div style="text-align: right; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-weight: normal; font-style: normal;">4</font></div>
      </div>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ef20040004_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.12.1.5274
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%--> <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 10.2<br>
        </font></div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><img src="image02.jpg"><font style="font-size: 10pt;"> </font></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXECUTIVE EMPLOYMENT AGREEMENT</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS EXECUTIVE EMPLOYMENT AGREEMENT (this &#8220;<font style="font-family: 'Times New Roman';"><u>Agreement</u></font>&#8221;), is made and entered into as of
        this 11<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of November 2024, by and between ATAI Life Sciences US, Inc. a Delaware corporation (the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;) and Gerd Kochendoerfer (the &#8220;<font style="font-family: 'Times New Roman';"><u>Executive</u></font>&#8221;). The Company and the Executive may each be referred to in this Agreement individually, as a &#8220;<font style="font-family: 'Times New Roman';"><u>Party</u></font>&#8221; and collectively, as the &#8220;<font style="font-family: 'Times New Roman';"><u>Parties</u></font>.&#8221;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; text-indent: 1pt; margin-right: 12.35pt; margin-left: 12.5pt; font-family: 'Times New Roman'; font-size: 10pt;">RECITALS</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the Company wishes to secure the services of Executive upon the terms and conditions hereinafter set forth commencing on or following a
        date to be mutually agreed upon by the Company and Executive, which date will be no later than <font style="font-family: 'Times New Roman';"><u>December 3, 2024</u></font>. The actual date on which Executive begins employment with the Company is
        referred to herein as the &#8220;<font style="font-family: 'Times New Roman';"><u>Effective Date</u></font>&#8221;.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, Executive wishes to render such services to the Company upon the terms and conditions set forth in this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">AGREEMENT</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the compensation and benefits provided by the Company and other good and valuable consideration, the receipt and
        sufficiency of which are hereby acknowledged, the Company and the Executive, intending to be legally bound, hereby agree as follows, effective on the Effective Date:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 36pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Employment.</u></font><font style="font-size: 10pt;"> The Company shall employ the Executive, and the Executive
                    shall be employed by the Company, under the terms and conditions set forth in this Agreement.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb874d8da7adc4baf98af2b5b6d6db28c">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Term.</u></font><font style="font-size: 10pt;">&#160; The Executive shall be employed at will, meaning that either the
                  Company or the Executive may terminate the Agreement and the Executive&#8217;s employment at any time for any reason or no reason, with or without cause, subject to the terms of this Agreement. The period of Executive&#8217;s employment hereunder is
                  hereinafter referred to as the &#8220;Term&#8221;.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z59844b18d66b426a865920bc6a915453">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Position; Duties; Place of Employment</u></font><font style="font-size: 10pt;">. During the Term, the Executive
                  shall have the position of Chief Operating Officer of the Company and its parent, ATAI Life Sciences N.V. (the &#8220;Parent&#8221;), and shall have the duties and responsibilities commensurate with such position, as well as such other duties and
                  responsibilities as the Board of Directors (or equivalent, e.g., the Management Board or Supervisory Board) of the Parent (in either case, the &#8220;Board of Directors&#8221; or the &#8220;Board&#8221;) and/or the Chief Executive Officer of the Company (the
                  &#8220;CEO&#8221;) or Parent may from time-to-time direct to the extent consistent with his position and status as set forth above, including, without limitation, providing various services to the Company&#8217;s Affiliates (as the term is defined in
                  section 4 below). During the Term, the Executive shall report to the Chief Executive Officer of the Company. The Executive&#8217;s principal place of employment shall be Oakland, CA, USA unless otherwise mutually agreed in writing by the
                  Company and the Executive. The Company may require the Executive to travel on behalf of Company domestically and abroad from time to time, including for board meetings of the Parent in Germany.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc92d9da6c048469f8212ea6167c8c1f0">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Obligations of Executive.</u></font><font style="font-size: 10pt;"> The Executive shall devote the Executive&#8217;s
                  services to the Company and shall perform the Executive&#8217;s duties faithfully and to the best of the Executive&#8217;s ability. The Executive shall devote the Executive&#8217;s full working time and best efforts to the business and affairs of the
                  Company and the Affiliates and will use his best efforts and business judgment, skill and knowledge to the advancement of the Company&#8217;s and Affiliates&#8217; interests and to the discharge of the Executive&#8217;s duties and responsibilities under
                  this Agreement. Executive shall not, at any time during the Term, directly or indirectly, render any business, commercial, or professional services that is directly related to the business in which the Company, the Parent or any Affiliate
                  is now involved or becomes involved during the term of Executive&#8217;s employment to any other person, firm, or organization, nor will Executive engage in any other activities that conflict with Executive&#8217;s obligations to the Company or any
                  of its Affiliates without the prior approval of the Board of Directors. For purposes of this Agreement,&#160; &#8220;<font style="font-family: 'Times New Roman';"><u>Affiliate</u></font>&#8221; means any person in control of, controlled by or under common
                  control with, the Company, the Parent, or any of their respective subsidiaries, parent companies, or related companies, divisions, predecessors, successors, interests, assigns, and/or entities in which each has an ownership interest, and
                  all persons acting by, through, under and/or in concert with any of foregoing.&#160; Notwithstanding the foregoing, the Parties agree that the Executive shall be permitted to provide consulting services for NFlection Therapeutics, PellePharm
                  ABC and/or Sol-Gel Technologies Inc., up to a cap of 10% in the aggregate of Executive&#8217;s working hours per month, subject to compliance with the terms of this Agreement and provided that such activities do not materially interfere with
                  Executive&#8217;s peformance of Executive&#8217;s duties and responsibilities hereunder or violate the terms of the Confidentiality and Developments Agreement to be executed in connection with the commencement of Executive&#8217;s employment; further
                  provided that should any of the aforementioned consulting services extend beyond six months from Effective Date, Executive shall obtain additional written consent from the CEO which shall not be unreasonably withheld.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z08a05042484d4e7082da03ee6582666f">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Salary and Benefits:</u></font><font style="font-size: 10pt;"> During the Term, in consideration of the
                  Executive&#8217;s agreement to be employed by the Company and for the services to be rendered under this Agreement, the Company agrees to provide compensation to the Executive as follows:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0ed62a61f69348ba87f5c36bfbd593fa">

          <tr>
            <td style="width: 63.8pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Salary</u></font><font style="font-size: 10pt;">.&#160; During the Term, the Executive shall be paid an annual salary
                  of $440,000 (as may adjusted from time to time in accordance herewith, the &#8220;Base Salary&#8221;) payable in equal semi&#8209;monthly installments or otherwise in accordance with the Company&#8217;s standard payroll cycle and practices, subject to applicable
                  tax related deductions and withholdings. Any increases in the Base Salary shall be determined in the sole discretion of the Board of Directors (and, for the avoidance of doubt, any increased Base Salary shall constitute &#8220;Base Salary&#8221; for
                  all purposes hereof).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3b940024bfd742ea8b0204e9d72ba4a4">

          <tr>
            <td style="width: 63.8pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">b.<br>
            </td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Bonus</u></font>.</u></font><font style="font-size: 10pt;">&#160; During the Term, the Executive shall be eligible to participate in an annual incentive program established by the Board. Executive&#8217;s annual incentive compensation under such incentive program (the &#8220;Bonus&#8221;) shall
                  be targeted at 40% of the Base Salary (the &#8220;Target Bonus&#8221;). The Bonus payable under the incentive program shall be based on the achievement of performance goals to be determined by the Board.&#160; The payment of any Bonus pursuant to the
                  incentive program shall be subject to the approval of the Board of Directors and Executive&#8217;s continued employment with the Company through the applicable date(s) of payment, except as provided in Section <a href="#_Ref69460648">7</a>.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcd3f24e16333449f84cd1bf66e42b2d3">

          <tr>
            <td style="width: 63.8pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">c.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Sign-On Bonus.</u> Within thirty (30) days of the Effective Date, the Company shall pay
                  Executive a lump sum payment of $75,000 less tax-related deductions and applicable withholdings (the &#8220;Sign-On Bonus&#8221;). Notwithstanding the foregoing, Executive and the Company acknowledge and agree that the Sign-On Bonus will not be
                  earned to any extent prior to the one (1) year anniversary of the Effective Date and will only be earned on the one (1) year anniversary of the Effective Date if Executive remains actively employed by the Company through such
                  anniversary.&#160; For clarity, if Executive resigns from the Company without Good Reason pursuant to Section 6(a)(vi) or is terminated for Cause (as hereinafter defined) within one (1) year of the Effective Date, Executive will be required to
                  (and shall) repay the Company the Sign-On Bonus within thirty (30) calendar days of his last day of employment with the Company, as follows: (a) 100% of the Sign-On Bonus if Executive&#8217;s termination date is prior to the six (6) month
                  anniversary of the Effective Date, or (b) 50% of the Sign-On Bonus if Executive&#8217;s termination date is on or after the six (6) month anniversary of the Effective Date.&#160; To the maximum extent permitted by applicable law Executive hereby
                  authorizes the Company to deduct such repayment as a valid set off of wages, any performance bonus, incentive compensation, outstanding expense report and/or other payments or compensation otherwise owed to Executive by the Company. For
                  the avoidance of doubt, if Executive is terminated without Cause or resigns for Good Reason, Executive does not have to repay any of the Signing Bonus.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4794b9a4e4ad4fbb9b8da3523a1fe943">

          <tr>
            <td style="width: 63.8pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">d.<br>
            </td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Reimbursement of Expenses</u></font>. During the Term, the Company shall reimburse the Executive for his reasonable business
                expenses incurred in the performance of Executive&#8217;s duties under this Agreement in accordance with applicable law and such policies as the Company may adopt from time to time.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4330b9ef5e7343d5b4832dcdaf5eaf6c">

          <tr>
            <td style="width: 63.8pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">e.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Benefits</u></font><font style="font-size: 10pt;">. During the Term, the Executive shall be eligible to
                  participate in employee benefit plans, programs and arrangements available to employees of the Company, subject to the terms and eligibility requirements thereof and as such plans, programs and arrangements may be amended or in effect
                  from time to time.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9f3eb14aec5f4832bdbc336611ec846c">

          <tr>
            <td style="width: 63.8pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">f.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Vacation.</u></font><font style="font-size: 10pt;"> During the Term, the Executive is allowed to take as much
                  leave as the Executive needs in accordance with Executive&#8217;s manager and the flexible-time off policy of the Company, subject to modification at the Company&#8217;s sole discretion from time to time. Thus, there is no accrued vacation time under
                  this flexible time-off policy to be paid out upon Executive&#8217;s termination for any reason.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z936b23b314f04b8b9b36af310f139ed1">

          <tr>
            <td style="width: 63.8pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">g.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Equity Grants</u></font><font style="font-size: 10pt;">.&#160; Subject to, and subsequent to, the approval of the Board
                  of Directors, Executive shall be eligible to receive an option to purchase 1,450,000&#160; shares of common stock of the Parent (the &#8220;Options&#8221;). The Options will have an exercise price per share equal to the fair market value of the underlying
                  shares on the date of grant, and will be <font style="font-family: 'Times New Roman'; color: rgb(36, 36, 36);">subject to a four (4) year vesting period</font> with a one (1) year cliff (i.e., 25% vesting upon the first anniversary of
                  the Effective Date and equal monthly vesting over 36 subsequent months thereafter, in all cases rounded down for any partial shares and subject in all cases to the Executive&#8217;s continued employment with the Company). For clarity, the
                  Options and grant thereof are expressly subject in all respects to (i) the approval of the Board of Directors, (ii) the Parent&#8217;s equity incentive plan, and (iii) the terms and conditions of the Option agreement(s).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 63.8pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">h.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Sick Leave</u>.</font><font style="font-size: 10pt;"> Executive will be eligible for sick time in accordance
                    with Company policy, as modified from time to time in the Company&#8217;s discretion. Currently, US-based employees are eligible to up to 80 working hours (10 days) of paid sick leave per calendar year, with up to ten (10) days carry over to
                    a subsequent year, except as provided by applicable law. Sick leave is not paid out upon termination of employment, unless otherwise required by applicable law.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9d5915df9e5b4edaabf57eadac64eb35">

          <tr>
            <td style="width: 63.8pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">i.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Withholdings.</u></font><font style="font-size: 10pt;"> The Company shall, in accordance with applicable law,
                  deduct from the Base Salary and all other amounts payable by the Company under the provisions of this Agreement to the Executive, or, if applicable, to his estate, legal representatives or such other beneficiary designated in writing by
                  the Executive, all social security taxes, all federal, state and municipal taxes and all other charges and deductions that now or hereafter are required by law to be charged on the compensation of the Executive or charged on cash benefits
                  (&#8220;Tax&#8221; or &#8220;Taxes&#8221;), irrespective of whether the Company or Parent is required to deduct.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zed0dbfe96c5e45e79c4e777e2349ffd0">

          <tr>
            <td style="width: 63.8pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">j.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indemnification.</u></font><font style="font-size: 10pt;"> The Executive shall be eligible for indemnification in
                  accordance with the terms of the Company&#8217;s or any Affiliates&#8217; organizational documents and any indemnification agreements entered into with the Executive, which indemnification shall remain in effect after the Term as it applies to the
                  Executive&#8217;s service to the Company to the same extent it applies to other executives of the Company.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcb091f0558cd4d8c8584b5c4e9fff6c4">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination.</u></font><font style="font-size: 10pt;"> Executive&#8217;s employment hereunder may be terminated by the
                  Company or Executive, as applicable, without any breach of this Agreement under the following circumstances, and the Term will end on the Date of Termination.&#160; &#8220;Date of Termination&#8221; shall mean (i) if Executive&#8217;s employment is terminated
                  by reason of Executive&#8217;s death, the date of Executive&#8217;s death; or (ii) if Executive&#8217;s employment is terminated pursuant to Section <font style="color: rgb(0, 0, 0);">6(a)(ii)-(vi), either</font> the date indicated in the Notice of
                  Termination or the date specified by the Company pursuant to Section 6(b), whichever is earlier.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z719f6c2c77a3490d9aff53aee1f77521">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Circumstances.</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</font><font style="font-size: 10pt;">The Executive shall cease to be an employee of the Company upon the occurrence of any of the following events:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z49f395c1fe904162b816b5b8f32c5a74">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">i.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Death</font><font style="font-size: 10pt;">. Executive&#8217;s employment hereunder shall terminate
                  upon Executive&#8217;s death.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5f31ba763bc740129f0869f9497f96ff">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">ii.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Disability</font><font style="font-size: 10pt;">. If Executive has incurred a Disability, as
                  defined below, the Company may terminate Executive&#8217;s employment.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdab9e84cf08f48aca0edc77c1fb8ee18">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">iii.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Termination for Cause</font><font style="font-size: 10pt;">. The Company may terminate
                  Executive&#8217;s employment for Cause, as defined below.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4f3a7ac398314b8a9b924e02de6bea25">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">iv.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Termination without Cause</font><font style="font-size: 10pt;">. The Company may terminate
                  Executive&#8217;s employment without Cause.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8d1a931b5b324cfca3aa608ce63dda87">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">v.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Resignation from the Company with Good Reason</font><font style="font-size: 10pt;">. Executive
                  may resign Executive&#8217;s employment with the Company with Good Reason, as defined below.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z80a5474e481e407a9e332c32dc055fab">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">vi.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Resignation from the Company without Good Reason</font><font style="font-size: 10pt;">. Executive
                  may resign Executive&#8217;s employment with the Company for any reason other than Good Reason or for no reason.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zed9bd8c0dc0d4d369311aabf569a3929">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notice of Termination</u></font><font style="font-size: 10pt;">.&#160; Any termination of Executive&#8217;s employment by the
                  Company or by Executive under this Section <a href="#_Ref69460431">6</a> (other than termination pursuant to Section 6(a)(i)) shall be communicated by a written notice to the other Party hereto (i) indicating the specific termination
                  provision in this Agreement relied upon, (ii) setting forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive&#8217;s employment under the provision so indicated, if applicable, and (iii)
                  specifying a Date of Termination which, if submitted by Executive, shall be at least thirty (30) days following the date of such notice (a &#8220;<font style="font-family: 'Times New Roman';"><u>Notice of Termination</u></font>&#8221;); <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that in the event that Executive delivers a Notice of Termination to the
                  Company, the Company may, in its sole discretion, change the Date of Termination to any date that occurs following the date of the Company&#8217;s receipt of such Notice of Termination and is prior to the date specified in such Notice of
                  Termination, but the termination will still be considered a resignation by Executive. A Notice of Termination submitted by the Company may provide for a Date of Termination on the date Executive receives the Notice of Termination, or any
                  date thereafter elected by the Company. The failure by either Party to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Cause or Good Reason shall not waive any right of the Party hereunder
                  or preclude the Party from asserting such fact or circumstance in enforcing the Party&#8217;s rights hereunder.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2524cba427be40e5912321de3e17fb97">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Company Obligations upon Termination.</u></font><font style="font-size: 10pt;">&#160; Upon termination of Executive&#8217;s
                  employment pursuant to any of the circumstances listed in this Section 6, Executive (or Executive&#8217;s estate) shall be entitled to receive the sum of:&#160; (i) the portion of Executive&#8217;s Base Salary earned through the Date of Termination, but
                  not yet paid to Executive; (ii) any expense reimbursements owed to Executive pursuant to Section <a href="#_Ref69460624">5</a>(d); and (iii) any vested benefits owed to Executive under any qualified retirement plan or health and welfare
                  benefit plan in which Executive was a participant in accordance with applicable law and the provisions of such plan.&#160; Except as otherwise expressly required by law (e.g., COBRA) or applicable plan, program, or arrangement or as
                  specifically provided herein, all of Executive&#8217;s rights to salary, severance, benefits, bonuses and other compensatory amounts hereunder (if any) shall cease upon the termination of Executive&#8217;s employment hereunder. In the event that
                  Executive&#8217;s employment is terminated by the Company for any reason, Executive&#8217;s sole and exclusive remedy shall be to receive the payments and benefits described in this Section <a href="#_Ref69460431">6</a>(c) or Section <a href="#_Ref69460648">7</a>, as applicable</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1430d1abe207498fba0dd76850b3cfde">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Deemed Resignation</u></font><font style="font-size: 10pt;">.&#160; If the Executive&#8217;s employment with Company
                  terminates for any reason, Executive shall be deemed to have resigned at that time from any and all positions that he may have held with Company or any Affiliates, as designated by Company or any Affiliates, or any other positions that
                  Executive held on behalf of Company or any Affiliates. If, for any reason, this Section 6(d) is deemed insufficient to effectuate such resignation, following a reasonable opportunity to review, Executive hereby authorizes Company and any
                  Affiliates to execute any documents or instruments consistent herewith which Company may deem necessary or desirable to effectuate such resignation or resignations, and to act as his attorney&#8209;in&#8209;fact. The Company will provide Executive
                  with a copy of such documents.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z68436bc195e34d9e8a33923af60cee3e">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';"><u>Payments upon Termination.</u></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcf931f9a6fc84606aa9c1a298dd78824">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination for Cause, or Termination Upon Death, Disability or Resignation from the Company Without Good Reason.</u></font><font style="font-size: 10pt;">&#160; If Executive&#8217;s employment shall terminate as a result of Executive&#8217;s death pursuant to Section 6(a)(i) or Disability pursuant to Section 6(a)(ii), pursuant to Section 6(a)(iii) for Cause, or pursuant to Section
                  6(a)(vi) for Executive&#8217;s resignation from the Company without Good Reason, then Executive shall not be entitled to any severance payments or benefits, except as provided in Section 6(c).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd10f7c50701b40949f6501414cc26e2b">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination without Cause, or Resignation from the Company with Good Reason</u></font><font style="font-size: 10pt;">.&#160; If Executive&#8217;s employment is terminated by the Company without Cause pursuant to Section 6(a)(iv), or pursuant to Section 6(a)(v) due to Executive&#8217;s resignation with Good Reason, then except as otherwise provided under Section
                  7(c) and subject to Executive signing on or before the 21st day (or, in the event of a group termination, the 45th day) following Executive&#8217;s Date of Termination, and not revoking, a release of claims substantially in the form attached as
                  Exhibit A to this Agreement (the &#8220;Release&#8221;) and Executive&#8217;s continued compliance with Section 9, Executive shall receive, in addition to payments and benefits set forth in Section 6(c), the following:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zce156425ee224ade884376529bdf6956">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">i.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">an amount equal to 0.75 times the Executive&#8217;s then-current annual Base Salary, payable in the form of salary continuation in regular installments over the nine (9) month period following the Date
                of Termination (the &#8220;Severance Period&#8221;) (payable in equal monthly or bi-weekly amounts or as a lump sum amount, at Company&#8217;s discretion) in accordance with the Company&#8217;s normal payroll practices;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6c813bfa6d4d4d4e8619b035de662f63">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">ii.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">subject to Executive&#8217;s eligibility and election of continuation coverage of group health coverage pursuant to COBRA, reimbursement or payment (at Company&#8217;s discretion) of the cost to continue
                Executive&#8217;s then-current level of group health coverage (including coverage of Executive&#8217;s eligible dependents) during the Severance Period; provided, that such reimbursement will cease if Executive receives coverage under a subsequent
                employer&#8217;s group health plan prior to the end of such Severance Period, notification of which Executive shall provide to Company within three (3) business days, and provided, further, that, notwithstanding the foregoing, if the Company
                determines that it cannot provide the benefit required by this clause (b)(ii) without potentially violating applicable law or incurring an excise tax, the Company shall in lieu thereof provide to Executive a taxable monthly payment in an
                amount equal to the monthly COBRA premium that Executive would be required to pay to continue Executive&#8217;s and the Executive&#8217;s covered dependents&#8217; group health coverage in effect on the Date of Termination (which amount shall be based on the
                premium for the first month of COBRA coverage), which payments shall be made regardless of whether Executive elects COBRA continuation coverage and shall commence in the month following the month in which the Date of Termination occurs and
                end on the earliest of (x) the last day of the Severance Period, (y) the date that Executive and/or Executive&#8217;s covered dependents become no longer eligible for COBRA and (z) the date Executive becomes eligible to receive healthcare
                coverage from a subsequent employer (and Executive agrees to promptly notify the Company of such eligibility); and</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5656f184176c4965ba5cc83e53f188ed">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">iii.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the earned but unpaid portion of the Annual Bonus, if any, for any calendar year ending prior to the calendar year in which the Date of Termination occurs (as determined by the Board in good faith
                for the performance year), which amount will be paid no later than April 30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the year in which the Date of Termination occurs.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z5656f184176c4965ba5cc83e53f188ed">

            <tr>
              <td style="width: 54pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
              <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
                <div style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Change in Control.</u></font>&#160; In lieu of the payments and benefits set forth in Section 7(b), in the event Executive&#8217;s employment is terminated
                  by the Company without Cause pursuant to Section 6(a)(iv), or pursuant to Section 6(a)(v) due to Executive&#8217;s resignation with Good Reason, in either case, on or within twelve (12) months following the date of a Change in Control, subject
                  to Executive signing on or before the 21st day (or, in the event of a group termination, the 45th day) following Executive&#8217;s Date of Termination, and not revoking, the Release and Executive&#8217;s continued compliance with Section 9, Executive
                  shall receive, in lieu of the payments and benefits set forth in Section 7(b), the following:</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2dce7d887d004963a2fdb14f774fbc3e">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">i.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">an amount in cash equal to the sum of (A) twelve (12) months of the Executive&#8217;s then-current Base Salary, and (B) the unpaid portion of the Target Bonus, if any, for any calendar year ending prior
                to the calendar year in which the Date of Termination occurs, as determined by the Board in good faith for the performance year, payable in a lump sum within sixty (60) days following the Date of Termination;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf81fafe194bd43f2ba464d607d2333ba">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">ii.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the benefits set forth in Section 7(b)(ii), provided that solely for this purpose, &#8220;Severance Period&#8221; shall mean the twelve (12) month period following the Date of Termination; and</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z85b5b78885704a70af8a9c71670b9c32">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">iii.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">subject to the approval of the Board, all unvested equity or equity-based awards that vest solely based on the passage of time and are then held by the Executive under any Company equity
                compensation plans shall immediately become 100% vested (with any such awards that vest in whole or in part based on the attainment of performance-vesting conditions being governed by the terms of the applicable award agreement), and the
                time period that the Executive may have to exercise any stock options shall be extended for a period equal to the shorter of (x) 12 months or (y) the remaining term of the applicable Option grant.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 36pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">8.</td>
              <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
                <div style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Certain Definitions.</u></font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;"><br>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb97073446fca45a2bb2b6b1c53c6c4ee">

            <tr>
              <td style="width: 36pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><u>Cause</u></font>.&#160; The Company shall have &#8220;Cause&#8221; to terminate Executive&#8217;s employment hereunder upon:</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the commission by the Executive of, or indictment of the Executive for, (A) a felony or (B) any misdemeanor involving moral turpitude, deceit, or intentional fraud (&#8220;indictment,&#8221; for these purposes, meaning an indictment, probable
              cause hearing or any other procedure pursuant to which an initial determination of probable or reasonable cause with respect to such offense is made);</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Executive&#8217;s gross negligence, willful misconduct or repeated insubordination with respect to the Company or any Affiliate;</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Executive&#8217;s use of alcohol or illegal drugs in a manner that impairs the performance of the Executive&#8217;s obligations under this Agreement;</font></font></div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Executive has engaged in misconduct that violates any applicable state or federal law prohibiting workplace harassment, including but not limited to sexual harassment, and/or discrimination, or that violates any written policy of
              the Company and/or Parent adopted to prevent workplace harassment or discrimination;</font></font></div>
        <div style="text-align: justify; margin-left: 108pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
            </font></font></div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </font>
        <div>
          <div style="text-align: justify; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Executive&#8217;s engagement in conduct which the Executive knows or reasonably should have known would cause the Company and/or Parent to violate any state, federal or international law, rule or regulation; or</font></font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(A) repeated failure of Executive to substantially perform his employment duties hereunder, (B) the Executive&#8217;s material breach of any of the material obligations of the Executive under this Agreement if such breach is not
                cured within five (5) days of notice of such breach to the Executive from the Board of Directors and/or the CEO; or (C) Company&#8217;s and/or Parent&#8217;s severe financial distress, whereby the Company is in the process of winding down its business
                and Executive&#8217;s employment is terminated in connection with such winding down.</font></font></div>
          <div style="font-size: 10pt;">&#160;</div>
        </div>
      </div>
      <font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </font>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7b7710fe34d8433bb5281bef3d4b756c">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Change in Control</u></font><font style="font-size: 10pt;">.&#160; &#8220;Change in Control&#8221; shall have the
                  following meaning for purposes of this Agreement:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any &#8220;person,&#8221; as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Act&#8221;) (other than Parent, any Affiliate, or any trustee, fiduciary or other person or entity holding securities under
            any employee benefit plan or trust of Parent or any Affiliate), together with all &#8220;affiliates&#8221; and &#8220;associates&#8221; (as such terms are defined in Rule 12b-2 under the Act) of such person, shall become the &#8220;beneficial owner&#8221; (as such term is defined
            in Rule 13d-3 under the Act), directly or indirectly, of securities of Parent representing fifty percent (50%) or more of the combined voting power of Parent&#8217;s then outstanding securities having the right to vote in an election of the Board of
            Directors of Parent (&#8220;<font style="font-family: 'Times New Roman';"><u>Voting Securities</u></font>&#8221;) (in such case other than as a result of an acquisition of securities directly from Parent); or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the consummation of (A) any consolidation or merger of Parent where the shareholders of Parent, immediately prior to the consolidation or merger, would not, immediately after the consolidation or merger, beneficially own (as such term is
            defined in Rule 13d-3 under the Act), directly or indirectly, shares representing in the aggregate more than fifty percent (50%) of the voting shares of Parent issuing cash or securities in the consolidation or merger (or of its ultimate parent
            corporation, if any), or (B) any sale or other transfer (in one transaction or a series of transactions contemplated or arranged by any party as a single plan) of all or substantially all of the assets of Parent<font style="font-family: 'Times New Roman'; font-style: italic;">.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the foregoing, a Change in Control shall not be deemed to have occurred (x) as a result of a financing transaction involving&#160;
        Parent&#8217;s equity securities, (y) as a result of a transaction that occurs to change the domicile of Parent, or (z) for purposes of the foregoing clause (i) solely as the result of an acquisition of securities by Parent that, by reducing the number
        of shares of Voting Securities outstanding, increases the proportionate number of Voting Securities beneficially owned by any person to fifty percent (50%) or more of the combined voting power of all of the then outstanding Voting Securities;
        provided, however, that if any person referred to in this sentence shall thereafter become the beneficial owner of any additional shares of Voting Securities (other than pursuant to a stock split, stock dividend, or similar transaction or as a
        result of an acquisition of securities directly from Parent) and immediately thereafter beneficially owns fifty percent (50%) or more of the combined voting power of all of the then outstanding Voting Securities, then a Change in Control shall be
        deemed to have occurred for purposes of the foregoing clause (i).&#160; Notwithstanding the foregoing, a Change in Control shall not have occurred unless the transaction or event constituting the Change in Control would also constitute a &#8220;change in
        control event&#8221; (as defined in Treasury Regulation &#167;1.409A-3(i)(5)) under Section 409A (defined below).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbbab76091f9c41d8ab711965dd91ffe9">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Code</u></font><font style="font-size: 10pt;">.&#160; &#8220;Code&#8221; shall mean the Internal Revenue Code of
                  1986, as amended, and the regulations and guidance promulgated thereunder.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z045e0bc31b5a4a5e8b6cc49166d2acbe">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Disability</u></font><font style="font-size: 10pt;">.&#160; &#8220;Disability&#8221; shall mean termination because
                  the Executive is unable due to a physical or mental condition to perform the essential functions of Executive&#8217;s position with or without reasonable accommodation for six (6) months in the aggregate during any twelve (12) month period or
                  based on the written certification by two licensed physicians of the likely continuation of such condition for such period.&#160; This definition shall be interpreted and applied consistent with the Americans with Disabilities Act, the Family
                  and Medical Leave Act, and other applicable law.&#160; In the event Executive&#8217;s employment is terminated based on the Executive&#8217;s Disability, then the Executive shall not be entitled to any severance payments or benefits, except as provided in
                  Section 6(c).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2890ab6df5484fcb8ee9535510d25c3b">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Good Reason</u>.&#160; &#8220;Good Reason&#8221; shall mean the Company&#8217;s material breach of any of the
                  material obligations of the Company under this Agreement, including a material reduction in base salary or a material diminution in position within the Company.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Notwithstanding the foregoing, no Good Reason will have occurred unless and until: (a) Executive resigns within ninety (90) days of Executive&#8217;s knowledge of the
                  occurrence of the facts and circumstances underlying the Good Reason event, (b) Executive has provided the Company, within sixty (60) days of Executive&#8217;s knowledge of the occurrence of the facts and circumstances underlying the Good
                  Reason event, written notice stating with specificity the applicable facts and circumstances underlying such finding of Good Reason; (c) the Company has had an opportunity to cure the same within thirty (30) days after the receipt of such
                  notice; and (d) the Company shall have failed to so cure within such period.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 36pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">9.</td>
              <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><u>Restrictive Covenants</u></font>.</td>
            </tr>

        </table>
      </div>
      <br>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbfce68f47e244fceae0acca5c46614d6">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Confidentiality and Developments</u></font><font style="font-size: 10pt;">.&#160; On or shortly
                  following the Effective Date, as a condition of Executive&#8217;s employment hereunder, the Executive shall sign and enter into the Parent&#8217;s standard form Confidentiality and Developments Agreement.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z614f1ead81e04fb5859faccdb716d8ff">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Nonsolicitation</u></font><font style="font-size: 10pt;">.&#160; During the Term and for a period of
                  twelve (12) months after the Date of Termination, Executive will not directly or indirectly solicit any individual who, at the time of the solicitation is an employee of or consultant to Company or any Affiliate to terminate his or her
                  relationship with the Company or any Affiliate.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <!--PROfilePageNumberReset%Num%11%%%-->
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 36pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(g)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Use of Material Undisclosed Information</u></font><font style="font-size: 10pt;">. The Executive acknowledges that it is the policy of the Company that all employees are prohibited from benefiting from the possession of material undisclosed information concerning the Company or any
                    Affiliates, providers or business partners (in each case provided they are listed on a national or international securities exchange) with respect to trading in the public securities markets. The Executive covenants and agrees that he
                    will abide by such policy.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u> </u></font><br>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 36pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(h)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Reasonable Restrictions</u></font><font style="font-size: 10pt;">. The
                    Executive further acknowledges and agrees that the provisions of this Section 9 are reasonable and properly required for the adequate protection of the Company&#8217;s business. Executive represents and warrants that (i) the restrictive
                    provisions of this Section 9 will not substantially impair Executive&#8217;s ability to earn a livelihood, nor will such provisions cause Executive undue hardship, and (ii) Executive has fully and carefully read this Agreement and has been
                    advised by the Company to consult with an attorney of Executive&#8217;s choice and that Executive fully understands and agrees with the provisions of this Agreement, including this Section 9.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u> <br>
          </u></font></div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 36pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Blue Penciling</u></font><font style="font-size: 10pt;">. If, at the
                    time of enforcement of any of the provisions of this Section 9, a court shall hold that the duration, scope, geographic area or other restrictions stated herein are unreasonable under circumstances then existing, Executive and the
                    Company agree that the maximum duration, scope, geographic area or other restrictions deemed reasonable under such circumstances by such court shall be substituted for the stated duration, scope, geographic area or other restrictions.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 36pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">10.</td>
              <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><u>Cooperation</u></font>.</td>
            </tr>

        </table>
      </div>
      <u> <br>
      </u>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Third&#8209;Party Agreements and Rights</u></font><font style="font-size: 10pt;">. The Executive hereby confirms that the Executive is not bound by the terms of any agreement with any previous employer or other party which restricts in any way the Executive&#8217;s use or disclosure of information or the Executive&#8217;s
                  engagement in any business. The Executive represents to the Company that the Executive&#8217;s execution of this Agreement, the Executive&#8217;s continued employment with the Company and the performance of the Executive&#8217;s duties for the Company or
                  any Affiliates will not violate any obligations the Executive may have to any such previous employer or other party. In the Executive&#8217;s work for the Company or any Affiliates, the Executive will not disclose or make use of any information
                  in violation of any agreements with or rights of any such previous employer or other party, and the Executive will not bring to the premises of the Company or any Affiliates any copies or other tangible embodiments of non&#8209;public
                  information belonging to or obtained from any such previous employment or other party.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 12pt; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u></u></font><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 36pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(j)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Litigation and Regulatory Cooperation</u></font><font style="font-size: 10pt;">. During and after the Executive&#8217;s employment with the Company, the Executive shall reasonably cooperate with the Company and any Affiliate in the defense or prosecution of any claims or actions now in existence
                    or that may be brought in the future against or on behalf of the Company or any Affiliate that relate to events or occurrences that transpired while the Executive was employed by the Company provided that such cooperation after the
                    termination of Executive&#8217;s employment with the Company does not otherwise interfere with the Executive&#8217;s subsequent employment and/or engagement with a subsequent employer and/or third parties. The Executive&#8217;s reasonable cooperation in
                    connection with such claims or actions shall include, but not be limited to, being available to meet with counsel to prepare for discovery or trial and to act as a witness on behalf of the Company and any Affiliate at mutually
                    convenient times. During and after the Term, the Executive also shall cooperate reasonably with the Company and any Affiliate in connection with any investigation or review of any federal, state or local regulatory authority as any such
                    investigation or review relates to events or occurrences that transpired while the Executive was employed by the Company. The Company or the applicable Affiliate shall reimburse the Executive for any reasonable out&#8209;of&#8209;pocket expenses
                    (including reasonable legal fees) incurred in connection with the Executive&#8217;s performance of obligations pursuant to this Section 10(b).</font></div>
              </td>
            </tr>

        </table>
        <font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u></u></font></div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 36pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(k)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Injunction</u></font><font style="font-size: 10pt;">. The Executive
                    acknowledges that any material breach by Executive of Executive&#8217;s obligations under this Agreement, including but not limited to the restrictions set forth in Section 9 hereof, would result in irreparable injury to the Company or an
                    Affiliate. The Company or the applicable Affiliate shall, therefore, be entitled, without restricting the Company or such applicable Affiliate(s) from other legal and equitable remedies, to injunctive and other equitable relief to
                    prevent or restrain the breach of this Agreement and to withhold compensation and benefits from the Executive if he fails to comply with this Agreement. Nothing in this Section shall be deemed to restrict any other remedy or right the
                    Company, any Affiliate or the Executive may have for any other breach of this Agreement.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;">
        <div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">11.<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;&#160; &#160; &#160; &#160;&#160;&#160; <u>Assignment</u></font>. This Agreement is personal to
            Executive, and Executive may not assign or delegate any of Executive&#8217;s rights or obligations under this Agreement without first obtaining the written consent of the Company. The Company may assign and delegate its rights and obligations under
            this Agreement, in each case in whole but not in part, without the prior consent of the Executive in the event that, and only in the event that, (a) the Company shall effect a reorganization, consolidate with, or merge into, any other
            corporation, partnership, organization or other entity, or transfer all or substantially all of its properties or assets to any other corporation, partnership, organization or other entity, (b) such corporation, partnership, organization or
            other entity referred to in the preceding clause &#8220;(a)&#8221; including without limitation any affiliate thereof shall by operation of law or expressly in writing assume all obligations of the Company hereunder as fully as if it had been originally
            made a party to this Agreement.</div>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt; text-indent: 36pt;"><font style="font-size: 10pt;">2.</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notices</u></font><font style="font-size: 10pt;">. All notices required under this Agreement shall be given by personal delivery deemed given on the date of receipt, or by postage prepaid certified or registered mail, return receipt requested, addressed to the
              Company or to the Executive as follows, or to such other address as either Party shall notify the other by like notice:</font></div>
        </div>
      </div>
      <br>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1a78a62365254d3bac8035e6b9ac495c">

          <tr>
            <td colspan="1" style="width: 5.27%; vertical-align: top;">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">If to the Company</font><font style="font-size: 10pt;">:</font></div>
            </td>
            <td style="width: 60%; vertical-align: middle;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ATAI Life Sciences US, Inc.</div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">c/o Industrious NYC</div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">250 W 34<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Street</div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">New York, NY 10019</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 5.27%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 35%; vertical-align: top;"><br>
            </td>
            <td rowspan="1" style="width: 60%; vertical-align: middle;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 5.27%; vertical-align: top; font-size: 10pt; text-align: left;">&#160;</td>
            <td style="width: 35%; vertical-align: top; font-size: 10pt; text-align: left;"><br>
            </td>
            <td style="width: 60%; vertical-align: top;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">with a copy to (by email)</div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Ryan Barrett, General Counsel</div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">[ <font style="font-family: 'Times New Roman';">&#9679;</font> ]</div>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 5.27%; vertical-align: top; font-size: 10pt; text-align: left;">&#160;</td>
            <td rowspan="1" style="width: 35%; vertical-align: top; font-size: 10pt; text-align: left;"><br>
            </td>
            <td rowspan="1" style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 5.27%; vertical-align: top;">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">If to the Executive</font><font style="font-size: 10pt;">:</font></div>
            </td>
            <td style="width: 60%; vertical-align: top;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Gerd Kochendoerfer</div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">[ <font style="font-family: 'Times New Roman';">&#9679;</font> ]</div>
              </div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">[ <font style="font-family: 'Times New Roman';">&#9679;</font> ]</div>
              </div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If sent by mail, such notice shall be deemed to have been given on the date of delivery set forth on the registered or certified mail receipt or upon the third (3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup>)
        day after mailing if delivery is refused.</div>
      <div style="font-size: 10pt;">&#160;
        <div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">3.<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Expenses of Enforcement</u></font>. In the event that any
            suit or legal proceeding is brought to enforce any provision of this Agreement, the prevailing Party in such suit or proceeding shall be entitled to receive all of such Party&#8217;s reasonable expenses, including reasonable attorneys&#8217; fees and
            costs, to the fullest extent permitted by law.</div>
        </div>
        <font style="font-size: 10pt;"> </font></div>
      <font style="font-size: 10pt;"> </font>
      <div style="font-size: 10pt;"> <font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div>
        <div>
          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">4.<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Advice of Counsel</u></font>. The Executive acknowledges
            that, in executing this Agreement, the Executive has had the opportunity to seek the advice of independent legal counsel, and has read and understood all of the terms and provisions of this Agreement. This Agreement shall not be construed
            against any Party by reason of the drafting or preparation hereof.</div>
        </div>
      </div>
      <font style="font-size: 10pt;"> </font>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div><font style="font-size: 10pt;"> </font>
        <div>
          <div style="text-align: justify; font-size: 10pt; text-indent: 36pt;">5.<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Section 409A</u></font>. This Agreement is
              intended to comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (&#8220;<font style="font-family: 'Times New Roman';"><u>Section 409A</u></font>&#8221;), and the Parties hereby agree to amend this Agreement as
              and when necessary or desirable to conform to or otherwise properly reflect any guidance issued under Section 409A after the date hereof without violating Section 409A. In case any one or more provisions of this Agreement fails to comply with
              the provisions of Section 409A, the remaining provisions of this Agreement shall remain in effect, and this Agreement shall be administered and applied as if the non-complying provisions were not part of this Agreement. The Parties in that
              event shall endeavor to agree upon a reasonable substitute for the non-complying provisions, to the extent that a substituted provision would not cause this Agreement to fail to comply with Section 409A, and, upon so agreeing, shall
              incorporate such substituted provisions into this Agreement. A termination of the Executive&#8217;s employment hereunder shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amount or
              benefit constituting &#8220;deferred compensation&#8221; under Section 409A upon or following a termination of employment unless such termination is also a &#8220;separation from service&#8221; within the meaning of Section 409A and, for purposes of any such
              provision of this Agreement, references to a &#8220;termination,&#8221; &#8220;termination of employment&#8221; or like terms shall mean &#8220;separation from service.&#8221; In the event that any payment or benefit made hereunder or under any compensation plan, program or
              arrangement of the Company would constitute payments or benefits pursuant to a non-qualified deferred compensation plan within the meaning of Section 409A and, at the time of the Executive&#8217;s &#8220;separation from service&#8221; the Executive is a
              &#8220;specified employee&#8221; within the meaning of Section 409A, then any such payments or benefits shall be delayed until the six-month anniversary of the date of Executive&#8217;s &#8220;separation from service&#8221;. Each payment made under this Agreement shall be
              designated as a &#8220;separate payment&#8221; within the meaning of Section 409A. All reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with the requirements of Section 409A to the extent that such
              reimbursements or in-kind benefits are subject to Section 409A. All reimbursements for expenses paid pursuant hereto that constitute taxable income to the Executive shall in no event be paid later than the end of the calendar year next
              following the calendar year in which the Executive incurs such expense or pays such related tax. Unless otherwise permitted by Section 409A, the right to reimbursement or in-kind benefits under this Agreement shall not be subject to
              liquidation or exchange for another benefit and the amount of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be
              provided, respectively, in any other taxable year.</font></div>
        </div>
      </div>
      <br>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Section 280G</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z14a41e08853c49baa8ea30c8ebfc6482">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Notwithstanding anything contained in this Agreement to the contrary, in the event that any payment or benefit received or to be received by the Executive (whether pursuant to
                the terms of this Agreement or any other plan, arrangement or agreement) (all such payments and benefits being hereinafter referred to as the &#8220;<font style="font-family: 'Times New Roman';"><u>Total Payments</u></font>&#8221;) would be subject (in
                whole or part), to the excise tax imposed under Section 4999 of the Code (the &#8220;<font style="font-family: 'Times New Roman';"><u>Excise Tax</u></font>&#8221;), then, after taking into account any reduction in the Total Payments provided by reason
                of Section 280G of the Code in any other plan, arrangement or agreement, then such remaining Total Payments shall be reduced, to the extent necessary so that no portion of the Total Payments is subject to the Excise Tax but only if (i) the
                net amount of such Total Payments, as so reduced (and after subtracting the net amount of federal, state and local income taxes on such reduced Total Payments and after taking into account the phase out of itemized deductions and personal
                exemptions attributable to such reduced Total Payments) is greater than or equal to (ii) the net amount of such Total Payments without such reduction (but after subtracting the net amount of federal, state and local income taxes on such
                Total Payments and the amount of Excise Tax to which Executive would be subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such
                unreduced Total Payments).</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2a1e891215de487c8c4a1c5399e662ae">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">For purposes of determining whether and the extent to which the Total Payments will be subject to the Excise Tax, (i) no portion of the Total Payments the receipt or enjoyment
                of which Executive shall have waived at such time and in such manner as not to constitute a &#8220;payment&#8221; within the meaning of Section 280G(b) of the Code shall be taken into account; (ii) no portion of the Total Payments shall be taken into
                account which, in the written opinion of an independent, nationally recognized accounting firm (the &#8220;<font style="font-family: 'Times New Roman';"><u>Independent Advisors</u></font>&#8221;) selected by the Company, does not constitute a
                &#8220;parachute payment&#8221; within the meaning of Section 280G(b)(2) of the Code (including by reason of Section 280G(b)(4)(A) of the Code) and, in calculating the Excise Tax, no portion of such Total Payments shall be taken into account which, in
                the opinion of Independent Advisors, constitutes reasonable compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the &#8220;base amount&#8221; (as defined in Section 280G(b)(3) of the Code)
                allocable to such reasonable compensation; and (iii) the value of any non-cash benefit or any deferred payment or benefit included in the Total Payments shall be determined by the Independent Advisors in accordance with the principles of
                Sections 280G(d)(3) and (4) of the Code.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Miscellaneous</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9e43ceff10dc48e3a36a21a6a5d808b7">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">This Agreement shall be governed by, and construed exclusively in accordance with, the laws of the State of California without giving effect to any choice or conflict of law
                rules to the contrary.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3cec605a99e74b6d82b9864dc4af7d46">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Should any provision of this Agreement be held invalid or unenforceable, the remainder of this Agreement shall not be affected and shall be enforceable to the fullest extent
                permitted at law or in equity.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6421fe4c35f347c3b0f0f4e70be94d59">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">This Agreement (together with the Exhibits hereto, if any) contains the entire agreement between the Parties concerning the subject matter hereof and supersedes all prior
                conversations, proposals, negotiations, understandings and agreements, whether written or oral, concerning the subject matter hereof.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zccdb2e63c4384542afa96478ee1f229c">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">This Agreement shall not be amended, altered, changed, modified, supplemented or rescinded in any manner except by written agreement executed by both Parties expressly
                referring to this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4e8080fe003c455094e6967eba650026">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving Party. The failure of any Party to require the performance of any term or
                obligation of this Agreement, or the waiver by any Party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5b3313800bac43c58f146c8103a0a30c">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be an original; but such counterparts shall
                together constitute one and the same document.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z802086a440f84aa0a76bcc7f4fcd566c">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(g)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">The Parties recognize that litigation in federal or state courts or before federal or state administrative agencies of disputes arising out of the Executive&#8217;s employment with
                the Company or out of this Agreement, or the Executive&#8217;s termination of employment or termination of this Agreement, or the Restrictive Covenants, may not be in the best interests of either the Executive or the Company, and may result in
                unnecessary costs, delays, complexities, and uncertainty. The Parties agree that any dispute between the Parties arising out of or relating to the negotiation, execution, performance or termination of this Agreement or the Executive&#8217;s
                employment, including, but not limited to, any claim arising out of this Agreement, claims under Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1967, the
                Americans with Disabilities Act of 1990, Section 1981 of the Civil Rights Act of 1966, as amended, the Family Medical Leave Act, the Executive Retirement Income Security Act, and any federal, state or local law, statute, regulation, or any
                common law doctrine, whether that dispute arises during or after employment, shall be settled by binding arbitration in accordance with the National Rules for the Resolution of Employment Disputes of the American Arbitration Association.
                The rules can be found at https;//www.adr.org/sites/default/files/EmploymentRules_Web.pdf/, or a copy will be provided upon request; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>,<font style="font-family: 'Times New Roman'; font-style: italic;"> however</font>,<font style="font-family: 'Times New Roman'; font-style: italic;">&#160;</font>that this dispute resolution provision shall not apply to any separate agreements
                between the Parties that do not themselves specify arbitration as an exclusive remedy. The location for the arbitration shall be San Diego, California. Any award made by such panel shall be final, binding and conclusive on the Parties for
                all purposes, and judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof. The arbitrators&#8217; fees and expenses and all administrative fees and expenses associated with the filing of the
                arbitration shall be borne by the Company; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>,<font style="font-family: 'Times New Roman'; font-style: italic;"> however</font>, that at the Executive&#8217;s option,
                Executive may voluntarily pay up to one&#8209;half the costs and fees. The Parties acknowledge and agree that their obligations to arbitrate under this Section survive the termination of this Agreement and continue after the termination of the
                employment relationship between Executive and the Company. The Parties each further agree that the arbitration provisions of this Agreement shall provide each Party with its exclusive remedy, and each Party expressly waives any right it
                might have to seek redress in any other forum, except as otherwise expressly provided in this Agreement. By election of arbitration as the means for final settlement of all claims, <font style="font-family: 'Times New Roman'; font-weight: bold;">the Parties hereby waive their respective rights to, and agree not to, sue each other in any action in a Federal, State or local court with respect to such claims, but may seek to enforce in court an arbitration award rendered
                  pursuant to this Agreement. The Parties specifically agree to waive their respective rights to a trial by jury, and further agree that no demand, request or motion will be made for trial by jury. Except as may be prohibited by applicable
                  law, the foregoing waiver includes the ability to assert claims as a plaintiff or class member in any purported class or representative proceeding.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; text-indent: -36pt; margin-left: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"><u>[Signature page to follow]</u></div>
      <div style="text-align: center; text-indent: -36pt; margin-left: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"><u> <br>
        </u></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Parties have duly executed this Agreement as of the date set below their respective names below.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z478206193b7e485abf0dd81b6df517bd">

          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">COMPANY</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">ATAI LIFE SCIENCES N.V.</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td rowspan="1" style="width: 47%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:<br>
              </div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">/s/ Florian Brand</font></td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name: Florian Brand</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title: Co-CEO</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Date: November 10, 2024</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">ATAI LIFE SCIENCES US, INC.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td rowspan="1" style="width: 47%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:&#160;</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">&#160;<font style="font-family: 'Times New Roman';">/s/ Srinivas Rao</font></td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td rowspan="1" style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name: Srinivas Rao</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td rowspan="1" style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title: Co-CEO</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Date: November 8, 2024</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">EXECUTIVE</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman';">/s/ Gerd Kochendoerfer</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Gerd Kochendoerfer</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">Date: November 11, 2024</td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%%%-->
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>EXHIBIT A</u></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Separation Agreement and Release</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Separation Agreement and Release (&#8220;<font style="font-family: 'Times New Roman';"><u>Agreement</u></font>&#8221;) is made by and between Gerd
        Kochendoerfer (&#8220;<font style="font-family: 'Times New Roman';"><u>Executive</u></font>&#8221;) and ATAI Life Sciences US, Inc., a Delaware corporation (together with any successor, the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;)
        (collectively referred to as the &#8220;<font style="font-family: 'Times New Roman';"><u>Parties</u></font>&#8221; or individually referred to as a &#8220;<font style="font-family: 'Times New Roman';"><u>Party</u></font>&#8221;).&#160; Capitalized terms used but not defined in
        this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, in connection with Executive&#8217;s termination of employment with the Company or a subsidiary or affiliate of the Company effective <font style="font-family: 'Times New Roman';"><u>_________</u></font>, 20<font style="font-family: 'Times New Roman';"><u>__</u></font>, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and
        demands that Executive may have against the Company and any of the Releasees as defined below, including, but not limited to, any and all claims arising out of or in any way related to Executive&#8217;s employment with or separation from the Company or
        its subsidiaries or affiliates but, for the avoidance of doubt, nothing herein will be deemed to release any rights or remedies in connection with Executive&#8217;s ownership of vested equity securities of the Company or one if its affiliates, vested
        benefits or Executive&#8217;s right to indemnification by the Company or any of its affiliates pursuant to contract or applicable law (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Retained Claims</u></font>&#8221;).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the severance payments and benefits described in Section [7(b)/7(c)] of the Employment Agreement, which, pursuant
        to the Employment Agreement, are conditioned on Executive&#8217;s execution and non-revocation of this Agreement, and in consideration of the mutual promises made herein, the Company and Executive hereby agree as follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Severance Payments and Benefits; Salary and Benefits</u></font>.&#160; The Company agrees to provide Executive with the severance payments and benefits described in Section [7(b)/7(c)] of the Employment Agreement, payable at the times
            set forth in, and subject to the terms and conditions of, the Employment Agreement. In addition, to the extent not already paid, and subject to the terms and conditions of the Employment Agreement, the Company shall pay or provide to Executive
            all other payments or benefits described in Section 6(c) of the Employment Agreement, subject to and in accordance with the terms thereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Release of Claims</u></font>.&#160; Executive agrees that, other than with respect to the Retained Claims, the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by the Company, any
            of its direct or indirect subsidiaries and affiliates, and any of its or their current and former officers, directors, equityholders, managers, employees, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans,
            plan administrators, insurers, trustees, divisions, and subsidiaries and predecessor and successor corporations and assigns (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Releasees</u></font>&#8221;).&#160; Executive, on Executive&#8217;s
            own behalf and on behalf of any of Executive&#8217;s affiliated companies or entities and any of their respective heirs, family members, executors, agents, and assigns, other than with respect to the Retained Claims, hereby and forever releases the
            Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, or cause of action relating to any matters of any kind, whether presently known or unknown,
            suspected or unsuspected, that Executive may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the date Executive signs this Agreement, including, without
            limitation:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">any and all claims relating to or
            arising from Executive&#8217;s employment or service relationship with the Company or any of its direct or indirect subsidiaries or affiliates and the termination of that relationship;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">any and all claims relating to, or
            arising from, Executive&#8217;s right to purchase, or actual purchase of any shares of stock or other equity interests of the Company or any of its affiliates, including, without limitation, any claims for fraud, misrepresentation, breach of
            fiduciary duty, breach of duty under applicable state law, and securities fraud under any state or federal law;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">any and all claims for wrongful
            discharge of employment; termination in violation of public policy; discrimination; harassment; retaliation; breach of contract, both express and implied; breach of covenant of good faith and fair dealing, both express and implied; promissory
            estoppel; negligent or intentional infliction of emotional distress; fraud; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices;
            defamation; libel; slander; negligence; personal injury; assault; battery; invasion of privacy; false imprisonment; conversion; and disability benefits;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">denial of protection or benefits under
            any and all claims for violation of any federal, state, or municipal statute, ordinance, executive order, regulation, including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Rehabilitation Act
            of 1973; the Americans with Disabilities Act of 1990; the Equal Pay Act; the Fair Labor Standards Act; the Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967; the Older Workers Benefit Protection Act; the Employee
            Retirement Income Security Act of 1974; the Worker Adjustment and Retraining Notification Act; the Family and Medical Leave Act; and the Sarbanes-Oxley Act of 2002, each as amended, and any other foreign, federal, state or local statute,
            ordinance, executive order, regulation or constitution regarding employment, termination of employment, discrimination, harassment, retaliation, health and safety, privacy, notice, or wage and hour matters;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">any and all claims for violation of the
            federal or any state constitution;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">any and all claims arising out of any
            other laws and regulations relating to employment or discrimination, harassment, or retaliation on the basis of any characteristic protected under law, including but not limited to race, color, national origin, sex, pregnancy, sexual
            orientation, gender identity, religion, disability, marital or parental status, age, union activity or other protected activity;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">any claim for any loss, cost, damage, or
            expense arising out of any dispute over the non-withholding or other tax treatment of any of the proceeds received by Executive as a result of this Agreement;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">any and all claims arising out of the
            wage and hour and wage payments laws and regulations of the state or states in which Executive has provided service to the Company or any of its affiliates (including without limitation the California Labor Law); and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">any and all claims for attorneys&#8217; fees
            and costs.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released.&#160;
        Executive acknowledges that Executive has been advised of and is familiar with the provisions of laws that may prohibit the release of unknown claims, including for example California Civil Code Section 1542, which states:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">A GENERAL RELEASE DOES NOT EXTEND TO CLIAMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF
        EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Executive, being aware of said code section, expressly waives all rights Executive may have thereunder, if applicable, as well as under any other statute or common law
        principles of similar effect. This release does not release claims that cannot be released as a matter of law, including, but not limited to, Executive&#8217;s right to report possible violations of federal law or regulation to any governmental agency or
        entity in accordance with the provisions of and rules promulgated under Section 21F of the Securities Exchange Act of 1934 or Section 806 of the Sarbanes-Oxley Act of 2002, or any other whistleblower protection provisions of state or federal law or
        regulation and any right to receive an award for information provided thereunder, Executive&#8217;s right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission, or any other local, state, or federal
        administrative body or government agency that is authorized to enforce or administer laws related to employment, against the Company for discrimination (with the understanding that Executive&#8217;s release of claims herein bars Executive from recovering
        such monetary relief from the Company or any Releasee for any alleged discriminatory treatment), claims for unemployment compensation or any state disability insurance benefits pursuant to the terms of applicable state law, claims to continued
        participation in certain of the Company&#8217;s group benefit plans pursuant to the terms and conditions of COBRA, claims to any benefit entitlements vested as the date of separation of Executive&#8217;s employment, pursuant to written terms of any employee
        benefit plan of the Company or its affiliates and Executive&#8217;s right under applicable law and any Retained Claims.&#160; This release further does not release claims for breach of Section 6(c) or Section [7(b)/7(c)] of the Employment Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Acknowledgment of Waiver of Claims under ADEA</u></font>.&#160; Executive understands and acknowledges that Executive is waiving and releasing any rights Executive may have under the Age Discrimination in Employment Act of 1967 (&#8220;<font style="font-family: 'Times New Roman';"><u>ADEA</u></font>&#8221;), and that this waiver and release is knowing and voluntary.&#160; Executive understands and agrees that this waiver and release does not apply to any rights or claims that may arise
            under the ADEA after the date Executive signs this Agreement.&#160; Executive understands and acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled.&#160;
            Executive further understands and acknowledges that Executive has been advised by this writing that:&#160; (a) Executive should consult with an attorney prior to executing this Agreement; (b) Executive has 21 days within which to consider this
            Agreement (provided, however, that in the event of Executive&#8217;s separation as part of a group reduction in force, he shall have forty-five (45) days within which to consider this Agreement), and the Parties agree that such time period to review
            this Agreement shall not be extended upon any material or immaterial changes to this Agreement; (c) Executive has seven business days following Executive&#8217;s execution of this Agreement to revoke this Agreement pursuant to written notice to the
            Company; (d) this Agreement shall not be effective until after the revocation period has expired; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of
            this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law.&#160; In the event Executive signs this Agreement and returns it to the Company in less than the
            21 (or 45) day period identified above, Executive hereby acknowledges that Executive has freely and voluntarily chosen to waive the time period allotted for considering this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Severability</u></font>.&#160; In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be
            illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision or portion of provision.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>No Oral Modification</u></font>.&#160; This Agreement may only be amended in a writing signed by Executive and a duly authorized officer of the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;"><br>
                </td>
                <td style="width: 50%; text-align: right;"><img src="image02.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Governing Law; Dispute Resolution</u></font>.&#160; This Agreement shall be subject to the provisions of Section 12 and Section 17(a) and (g) of the Employment Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Effective Date</u></font>.&#160; Executive has seven business days after Executive signs this Agreement to revoke it and this Agreement will become effective on the day immediately following the seventh&#160; business day after Executive
            signed this Agreement, so long as it has been signed by the Parties and has not been revoked by Executive before that date.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">8.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Voluntary Execution of Agreement</u></font>.&#160; Executive understands and agrees that Executive executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with
            the full intent of releasing all of Executive&#8217;s claims against the Company and any of the other Releasees.&#160; Executive acknowledges that:&#160; (a) Executive has read this Agreement; (b) Executive has not relied upon any representations or statements
            made by the Company that are not specifically set forth in this Agreement; (c) Executive has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of Executive&#8217;s own choice or has elected not to
            retain legal counsel; (d) Executive understands the terms and consequences of this Agreement and of the releases it contains; (e) Executive is fully aware of the legal and binding effect of this Agreement; and (f) Executive has had 21 (or 45)
            days to review this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcb3a844ff5a94947b137ff72986a588f">

          <tr>
            <td colspan="3" style="vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">EXECUTIVE</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" rowspan="1" style="vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 35%; vertical-align: top;"><br>
            </td>
            <td rowspan="1" style="width: 15%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Dated:</font></div>
            </td>
            <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24.95%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="vertical-align: top; border-top: 2px solid rgb(0, 0, 0); padding-bottom: 2px; width: 35%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Gerd Kochendoerfer</div>
            </td>
            <td style="vertical-align: top; padding-bottom: 2px; width: 15%;">&#160;</td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">ATAI LIFE SCIENCES US, INC.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="3" style="vertical-align: top;" rowspan="1">&#160;</td>
            <td style="vertical-align: top; width: 3%;" rowspan="1"><br>
            </td>
            <td style="vertical-align: top;" rowspan="1" colspan="2"><br>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
            <td style="vertical-align: top; width: 3%; padding-bottom: 2px;" rowspan="1"><font style="font-size: 10pt; font-family: 'Times New Roman';">By:</font><font style="font-size: 10pt;"> </font></td>
            <td style="vertical-align: top; width: 32%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
            <td style="vertical-align: top; width: 15%; padding-bottom: 2px;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Dated:</font><font style="font-size: 10pt;"> <br>
                </font></div>
            </td>
            <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 24.95%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="vertical-align: top; width: 3%; padding-bottom: 2px;"> <br>
            </td>
            <td style="vertical-align: top; width: 32%; padding-bottom: 2px;">
              <div style="text-align: left; text-indent: -17.1pt; margin-left: 17.1pt; font-family: 'Times New Roman'; font-size: 10pt;">Name:</div>
            </td>
            <td style="vertical-align: top; width: 15%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="3" style="vertical-align: top;" rowspan="1">&#160;</td>
            <td style="vertical-align: top; width: 3%;" rowspan="1"><br>
            </td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">Title:</td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt; text-align: right;">
        <div>&#160;<font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <hr noshade="noshade" style="height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); margin-left: auto; margin-right: auto; border: medium none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ef20040004_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.12.1.5274
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;">
      <div><font style="font-weight: bold;">Exhibit 99.1</font><br>
      </div>
      <div><br>
      </div>
      <img src="image00003.jpg"></div>
    <div> <br>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health</div>
        <div><br>
        </div>
        <div>
          <div style="text-align: center; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">-</font>&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Srinivas Rao</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic; color: #292D39;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">M.D.,
                Ph.D. succeeds as sole Chief Executive Officer</font></font></div>
          <div style="text-align: center; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> <br>
              </font></font></div>
          <div style="text-align: center; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">-</font>&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Kevin Craig, M.D. promoted to
              Chief Medical Officer</font></div>
          <div style="text-align: center; margin-left: 18pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br>
            </font></div>
          <div style="text-align: center; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">-</font>&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Glenn Short, Ph.D. promoted to
              Chief Scientific Officer</font></div>
          <div style="text-align: center; margin-left: 18pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br>
            </font></div>
          <div style="text-align: center; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">-</font>&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Gerd Kochendoerfer Ph.D. joins as
              Chief Operating Officer</font></div>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_1fob9te"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">NEW YORK and BERLIN, January
            10, 2025</font> &#8211; atai Life Sciences (NASDAQ: ATAI) (&#8220;atai&#8221; or &#8220;Company&#8221;), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced key leadership appointments to advance its goal
          of delivering novel mental health therapeutics. Srinivas Rao<font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(41, 45, 57);">&#160;</font>M.D., Ph.D., has assumed the role of sole Chief Executive Officer (CEO), joined
          by the promotions of Kevin Craig, M.D., to Chief Medical Officer (CMO), Glenn Short, Ph.D., to Chief Scientific Officer (CSO) and the appointment of Gerd Kochendoerfer, Ph.D., as Chief Operating Officer (COO).</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;We have strengthened our leadership team at a pivotal time as we advance VLS-01 and EMP-01 into Phase 2 clinical trials,&#8221; stated Dr. Srinivas Rao, CEO and
          Co-founder of atai. &#8220;Kevin, Glenn and Gerd bring exceptional expertise that will further enhance our capabilities in clinical development, scientific innovation and operational excellence. It is a privilege to lead atai during this critical phase
          of our evolution, supported by a world-class team of biotech and pharmaceutical experts. As we continue to focus on executing our Phase 2 clinical trials, with VLS-01 now screening patients, we look forward to the Phase 2b data readout for
          Beckley Psytech&#8217;s BPL-003, anticipated mid-year. This is a key milestone and an important step towards the potential of commercially scalable short-duration psychedelic therapies for people with treatment-resistant depression.&#8221;</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">As announced in May 2024, Co-Founder Srinivas Rao, M.D., Ph.D., was promoted to Co-CEO effective June 1, 2024, and assumed the role of CEO on January 1,
          2025. Dr. Rao has over 24 years of diverse biotechnology and pharmaceutical experience, having held the titles of Chief Scientific, Medical, and Executive Officer at companies ranging from venture-backed startups to vertically integrated,
          publicly traded pharmaceutical companies.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Kevin Craig, M.D., has been named CMO to head clinical development for VLS-01 (buccal film DMT) and EMP-01 (R-MDMA). Dr. Craig served as atai&#8217;s Senior Vice
          President of Clinical Development since July 2023 and he leads the entirety of atai&#8217;s clinical-stage research &amp; development effort, clinical development, patient safety, clinical operations, regulatory affairs, biostatistics and all other
          clinical functions. Dr. Craig has been a member of atai&#8217;s leadership team since 2021, and he has over 20 years of clinical experience, with 13 years in the industry and a decade in clinical and academic settings. Prior to joining atai, he was
          Head of Early Clinical Development at Jazz Pharmaceuticals (formally GW Pharmaceuticals) where he was responsible for the design and execution of rapid decision-making clinical trials across the early neuroscience pipeline. Before joining the
          industry, Dr. Craig held a faculty appointment at the Behavioral and Clinical Neuroscience Institute at the University of Cambridge and has published widely on cognition and brain imaging in mental health. He received his medical degree from the
          University of the Witwatersrand, South Africa, and his MPhil from the University of Cambridge. He was trained in Psychiatry in Cambridge, UK and is a UK board-certified psychiatrist.</div>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
          <div style="width: 100%;" class="BRPFPageHeader">
            <div style="text-align: right;"><img src="image00003.jpg"></div>
          </div>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Glenn Short, Ph.D., has been named CSO to lead atai&#8217;s research programs including discovery, nonclinical pharmacology, preclinical development and
          Chemistry, Manufacturing &amp; Controls and to advance internally discovered, novel 5-HT2AR agonists with non-hallucinogenic potential. Dr. Short has served as Senior Vice President of Early Development since August 2022 has been a member of
          atai&#8217;s leadership team since 2019. He has over 20 years of industry and research experience and has been involved in numerous programs that leverage cutting-edge biotechnologies to develop new therapies to address unmet medical needs in oncology,
          immunology, neurological disease, and pain. Dr. Short holds a Ph.D. in Chemistry from the University of Virginia and conducted his postdoctoral training in Molecular Biology at Massachusetts General Hospital/Harvard Medical School in Boston.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Gerd Kochendoerfer, Ph.D., has been named COO to foster strategic alignment and operational excellence as the company progresses its key clinical programs.
          Dr. Kochendoerfer has more than 25 years of experience in leadership roles across the pharmaceutical and biotech sectors. He has a strong track record in drug development, corporate development and team leadership. Dr. Kochendoerfer has led
          technology innovation, pipeline growth, and strategic alliances, as well as overseeing business operations and quality infrastructure. Prior to joining atai, he was COO at NFlection Therapeutics, Inc. and Senior VP and Head of Operations at
          PellePharm Inc., a BridgeBio company. He also held leadership positions at Depomed Inc., FibroGen Inc., and Gryphon Therapeutics, Inc. Dr. Kochendoerfer holds a Ph.D. in Chemistry from UC Berkeley, is an inventor on multiple patents and has
          published more than 25 papers in peer-reviewed literature.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About VLS-01 (buccal film DMT)</div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">VLS-01 (VLS-01-BU) is a proprietary oral transmucosal film formulation of N,N-Dimethyltryptamine (DMT) applied to the buccal surface, being developed for
          people living with treatment-resistant depression (TRD). Pharmacologically, DMT is a partial agonist of the 5-HT 1A/2A/2C receptors, developed to induce a short duration of psychedelic effect. Clinical evidence suggests that a single
          administration of intravenous (IV) DMT results in rapid-acting and durable antidepressant effects in patients with major depressive disorder. The buccal film formulation is designed with the aim to eliminate the need for IV administration,
          provide improved pharmacokinetics (PK) compared to such route of administration, and maximize the therapeutic potential to fit into the established two-hour in-clinic treatment paradigm. atai is conducting a Phase 2, multicenter, double-blind,
          randomized, placebo-controlled, trial to assess the efficacy, safety and tolerability of multiple doses of VLS-01 in people with TRD. Topline data from the Phase 2 study is anticipated in the first quarter of 2026.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About EMP-01 (R-MDMA)</div>
        <div style="text-align: justify; color: rgb(36, 36, 36); font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">EMP-01 is a proprietary oral formulation of the R-enantiomer of
              3,4-Methylenedioxymethamphetamine (MDMA) being developed for the treatment of social anxiety disorder (SAD). EMP-01's pharmacology is more targeted than </font>racemic <font style="font-family: 'Times New Roman'; font-size: 10pt;">MDMA, preferentially targeting the serotonergic system with less </font>activation of other biological targets associated with some side effects observed with racemic MDMA<font style="font-family: 'Times New Roman'; font-size: 10pt;">. In a Phase 1 clinical trial, EMP-01 was</font> safe and<font style="font-family: 'Times New Roman'; font-size: 10pt;"> well-tolerated and found </font>to
          produce subjective experiences and altered states that were more similar to those of classic psychedelics than racemic MDMA, with participants also reporting having an introspective experience, emotional breakthroughs, and increased
          self-compassion<font style="font-family: 'Times New Roman'; font-size: 10pt;">. atai plans to initiate an exploratory Phase 2a placebo-controlled clinical trial in the first quarter of 2025 to assess the safety and
              efficacy of two doses of EMP-01 in adults with SAD. Topline data from the Phase 2a study is anticipated in the first quarter of 2026.</font></div>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
          <div style="width: 100%;" class="BRPFPageHeader">
            <div style="text-align: right;"><img src="image00003.jpg"></div>
          </div>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About atai Life Sciences</div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. The Company was founded in response to the
          significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to developing novel, evidence-based therapeutics to treat depression, anxiety and other mental health disorders. atai's vision is to heal
          mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>www.atai.life</u></font>.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Forward-looking Statements</div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. We intend
          such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The
          words &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;initiate,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;potentially,&#8221; &#8220;preliminary,&#8221; &#8220;likely,&#8221; and similar expressions are intended to identify forward-looking
          statements, although not all forward-looking statements contain these words. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without
          limitation, statements relating to our expectations relating to management and our leadership team; our business strategy and plans; the potential, success, cost and timing of development of our product candidates, and the product candidates of
          those companies we invest in, including the progress of preclinical and clinical trials and related milestones such as VLS-01 and EMP-01 and the anticipated data readout for BPL-003; and the plans and objectives of management for future
          operations, research and development and capital expenditures.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to
          differ materially from those projected, including, without limitation, the factors described in the section titled &#8220;Risk Factors&#8221; in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) on March 28,
          2024, as such factors may be updated from time to time in atai's other filings with the SEC. atai disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, other than to the extent
          required by applicable law.</div>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
          <div style="width: 100%;" class="BRPFPageHeader">
            <div style="text-align: right;"><img src="image00003.jpg"></div>
          </div>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Contact Information</div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Investor Contact:</div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><u>IR@atai.life</u></div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Media Contact:</div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><u>PR@atai.life</u></div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>atai-20250107.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.12.1.5274 Broadridge-->
<xs:schema targetNamespace="http://atai.life/20250107" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:atai="http://atai.life/20250107" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="atai-20250107_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="atai-20250107_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://atai.life/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>atai-20250107_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.12.1.5274 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityExTransitionPeriod" xml:lang="en-US" id="dei_EntityExTransitionPeriod">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod" xlink:title="label: EntityExTransitionPeriod to dei_EntityExTransitionPeriod" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>atai-20250107_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.12.1.5274 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://atai.life/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="atai-20250107.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://atai.life/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: CoverAbstract to EntityExTransitionPeriod" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image01.jpg
<TEXT>
begin 644 image01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  H &<# 2(  A$! Q$!_\0
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M#?Q)TCQ!X]UGPE9P7J:CI08SO(@$;;6"G:0<]6':O!_"6K_$>\^,FJ^"M?\
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MQ]I27+T/C'B(Y9G%2IB=(U%H_N_RU^1['7CGC?9;_$!Y+; <"-VV_P![ _\
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M=D4<)0P[O2@H^B)*,#.<<T45)T 0#U&:" >HSWHHH ,#.<#/3-&!G..:**
6@$8(!'O1@9SCFBB@   Z#%%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image02.jpg
<TEXT>
begin 644 image02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  K 'X# 2(  A$! Q$!_\0
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M$Z<*4I5OAMKZ'D7@>1[37G4'@$*V/KC^M>W6IS"OXC]:\7\#V;SWRRD',L@
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M^RDQQP!"BE) AW9QE^>G<55UC2KZ2XG-C9Q2.\N_=<%2A&.S##@_[)XKK**
#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  P (\# 2(  A$! Q$!_\0
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MRI_PZ@9%5#VB7/U)KK;YJ2;/B*4(T,ZJ0H[.U_5J_P"9Z+("48+P2, U\>?
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,W(Z$KTSP/R% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45986389783184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 07, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  07,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ATAI LIFE SCIENCES N.V.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001840904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">P7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Wallstra&#223;e 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Berlin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">89 2153 9035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares, &#8364;0.10 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATAI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " #I.BI:!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .DZ*EH*>;@
M[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( .DZ*EJ97)PC$ 8  )PG   3              "  <P!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ Z3HJ6BHW-;]O!   +1$
M !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( .DZ*EJ?H!OPL0(  .(,   -              "  ;(,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ Z3HJ6I>*NQS     $P(   L
M         ( !C@\  %]R96QS+RYR96QS4$L! A0#%     @ Z3HJ6APX9>H_
M 0  / (   \              ( !=Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( .DZ*EHD'INBK0   /@!   :              "  >,1  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( .DZ*EIED'F2&0$
M ,\#   3              "  <@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  !(4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20040004_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://atai.life/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>atai-20250107.xsd</File>
    <File>atai-20250107_lab.xml</File>
    <File>atai-20250107_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20040004_8k.htm">ef20040004_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20040004_8k.htm": {
   "nsprefix": "atai",
   "nsuri": "http://atai.life/20250107",
   "dts": {
    "schema": {
     "local": [
      "atai-20250107.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "atai-20250107_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "atai-20250107_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ef20040004_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 30,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://atai.life/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20250107to20250107",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20040004_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20250107to20250107",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20040004_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://atai.life/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001140361-25-000708-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-000708-xbrl.zip
M4$L#!!0    ( .DZ*EIJ]4FX3@,  *</   1    871A:2TR,#(U,#$P-RYX
M<V2U5UUOTS 4?4?B/YB\.Q_]8+1:-X&VH4F#H0$2;\A-;EH+UPFVL[7_'MN)
MT_23IH$WQS[GW&/[7MNYO%XN&'H&(6G&)U[DAQX"'F<)Y;.)5TA,9$RI=WWU
M^M7E&XP_ @=!%"1HND(?1$8209,9H"]/CREE@'H#/^KYD3_L70P:XQ@;_E*.
M93R'!4&*B!FHSV0!,B<Q3+RY4ODX"(@BU&<TA: 7]H9A%%YH-PP6P-5=)A8W
MD)*"J8GWNR :12'QD+;/Y7@I:XV7EQ?_I>]G8J9%PBCX\>GAJXWJL";(T8@E
MC%'^:T-T.17,R?8#,SPE$FH'._C*1#0:C0([6D.U$#TB3;E4A,?0Q">J)C3!
MPZ <=- $Z"9.0NS/LN= #Y@9#FJ@$EBM<I#[?>CAP P;3@^'?=R/'%/GQ"8Q
M)7)J26YD(Y 4ZA"^'BH).D40,DE".,\443HA;5?5F>>4IUG5H_O,BH[=+CQ!
MBNP:CXW@Q)-TD3.S@+9O+B"=>&:KL=OEG[D 7SMT$)$Q.+(E9CC0%*DST3I[
M6 =V$D3$.RH[.:!%LAR$HGK6ZQ0*_MFT&)FVG9:F /N_\S$ZW_0,D&E\?[K?
M4W[6RDT6%Z;8W_/DEBNJ5O=ZR\7"KKB':#+QCB+JJ"YN BGEU&92J,^",$08
M.85FD_ $E7*HH7<9;(MLZQ<2DD=^9=O;V5&Q*\@Q9DQ87+ SB&MGAWE5K]L!
M5U'!5DF5'9N%9\I.)UPF%.([1W6SZF>$Y%71EP?\0Q9;F1(MW6&TEQ, 4]+U
MF$0>^$N9N!PZZN' "7?4PS;<-#I$C;."*[%J$[E)<1]='!1"Z!N[G84FI_[J
M8 *6\;R-@1IO6QT"<T)CV2;RFE V.\26-&X3V<%-HUW4[8-[5)Z6'&;F*;8_
M_#:-";'!PD8'1ST<O>WN0[7VH,Z)O[F<*A>MEM_A;:O;!C3?:*=,W%+,%W8\
M,_V^F7X_.MO%(!#FMC[1@$6;L ,<OL-1V&[5=]Z;)T9U!!-X>'+(0T_*#K>+
ME>E:=M632/N+%89ES@@G*A.K._U]>@DT56[7(N=41/,MW6J-'+Y<'_,2;[4T
MA][P9T?ONCU[?U@.F?D;TW[+,Z_C5=+J)J[@IK$U??LD*T6N_@!02P,$%
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M'+PSFBCNY@]'-NV2E_;<CN+:$EZ( _+?#6PB\H?\>OZG_P%02P,$%     @
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MN<_BC 4D3[;)^6PZY3DYXC'(.:>1'";_?4[\V93%.?$%HSD,GV6@V,@GD=!
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MK:(9!NJ$ KD DK?-D2=;^Z\ BLTCT%_@JIS(I)$@^JO6#8#TD!S(%'9 SH$
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M(AS_265O%-)@]&I\M44!*W#8*;FC2A!4J:$B,W31,F$JS] I7 ^]")P9X6J
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M*Y$DUP/<"7'K ?\F\M*Q+C0\8"2)#'!LW$U]$NZR1-AC+ NKSQ/5Z4/=54V
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MGG%Z"32>O;U%(<N";()'P;&)R0B9G!?*\BL_ ^TA88B6!A0_MGC6\<(Z6FG
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M[^//+CP05-#]&J#91;^P#!TWBPXF-*<RIZ+2 ER45D&#*+6C6>7>B@FH/>A
MY@LI/Y'CAO$I:WD WJFUV1HKLZ6]$:JV [EK8#B$48*4P:(+D*WAEE%"<,V\
M  U?$6.[PA'I\US[0WV+VG4-I6*-?V M<X[8R]*Q;%J/Y94R.IBU"AJHO T.
MJG?V9[T=EUG,1@5H.LPJO^QP>F,XPB$)!B0U71[Y!'K5P\CJQP)Z[)%8R]>*
M5;<_E]K"/:;C<#5<^JO)9!&A7709C>5JL1S/5N%*CB>K^V%Q-_"@_2*F[IM!
M.=B/DWC;C&Q_?O0@1V:Q-Z)Z[\QYE+>I#?$@,]N; _VFJ2Z9W7HLZX^*/]^_
M/GVH>$]2_IS,(S$2JU!,%V(Z&84B"&;3<"'"V5 $8G(P%-U-_A2'*B^5.S.=
MA$'[&W*8O6;\SAK9 Y^R[$=]OKA.P/T?*A>S$5>_;UFY-S>X[-JX323B@>)>
M)>46P-%M(:PX76ORVS!&>TK>;'D%FF\N?^^SE^I1AP]FARR'9@X7/)#V*1"V
M#Y)J^6A_3BV&8["P<>TXRI#&/6?"=E(\).<X!$(]="#4_! (]4T&0CT9&6DX
MCI;^,IJ#BC6;RFCASQ9S?S&?3\5X/A'A^" C/4B6SC=GHYM-%I/;8*EUA*@&
MT,2@)2)UV'*?S-1.MW;[YFX?HM 8Y1:YY/+X!F'DV LKV0C%<8HCW?1Q$CUD
M-]JE)V*%!8J6/0UC'.RJKHV((.R<K)$IRRE8'(_68#PJ2BRNCL%8@V;:!9KO
M/.0"&]LXR9D3TQE, 5X[MAQDW4D[XZ9PC&POO,S00CH@432A6!8L.HRY0@65
M>2MAD6,,O7$M@QHJ3&2-+B817*!CM(!17,1^7'JG;$VTS;*ZP!&]HRH@5)N0
MC@0[F> P<+I'@4VI1XS;[]KRFZD0JV984]-_AL.+TU(M)?[5G:9=1_D]?ZO3
M=8Z4*XTVA"H?N98!G7Y6YEJ]XW9EO$A78%23&ZB_U+OD=U.";I5:T\5%0:?L
M,>_:MIK &+F4Q'7 ESZ6JZYC6T7R<-'BD.OI4FJ8,ZK'SJO88K5E.H R]*")
MW_W\B3L(.X+,[D+2W=B$DM21A?:C'YBHRSVJVHA4.PBH]G5_23"DBL\8G[VT
M0S0'QF%@$P%T#7,$ISJ5NOI:>^MS>5[!<^0[A_.HM+=+[8>YD@G&IH[&*GM/
MEP)O)G2YLI3LR[PWV_Q@-,K?J#]' I]W9,V;UTZ7"$>B'H.6(C\EQN%R[ C$
M;*^%*Q^-]1E<XSPCA[P(,).I>+&O5/UGNPJ[W04G@ZYE%JHDR$85BHE,%"%%
MGF&?ZP!/+*@\7.(>F;2*W35?6')*>]LI1G;0#$DFT49Y.(]$V3D6=4[DL0GY
MS@J:AF8#-]WA!,YXTC_@HSC%%#2J#V3-KF^1*/=X(\EC5J#HE>O+V;Y++XS0
MI-)+D?UUR8*]&,03.<#6KK93YQR:$2I)@"06N)3XLO*5YF; C?E2('4CCY.*
M':G(EO;8!Y0A;,HY4A7=9@ V<U4=-P--VG(M44B=C0P"FPK1,>O17H6HRE'X
MY'6BOK$5%,5"O;HH.YYG)+G%S;(:H61!4:J8+A## I&B9&%&=U$'E-OQVR2H
M@4R$ KCVTFJQ?).A\$."H'<99PFGN[=$+XJ%PG-&WY$PC9[E4GQNIOKR8L&J
M)+&L'-0PE[#"UEK6RRRP,>I/$UU]6Y#,NGF:?I+N&Z98KN-JW0[+N\JJ)+2C
M%)0P=,/-TC'T+JGLDM)UZ]NAJX>Z[UU=NK-KM^[E=7P*U:1-Q*(/%\84[M+S
MC93[/HISH!?,5#&XCQ9%CT+7@ZK%0-/H6H2X..<B#Q,0O^U*TO4J$J$L3*,N
M2DG:$4?.9^NU5)FK9I\Z5Z'!\'G8)O^A;UU4]C>1[KJ$&=>T*D@1./I\3)\E
M0FE>BIAV+_[1]7&=]MPZ--#!#TZ[=W?S80EAOA+Q<I(,Q/^\6:Z65XQ23/Y]
M[$J<;V5=<VL6$;:"\_ED!9@V8E:=XU-=Y-$[:F@57*JV4"@1ZTV)"A?2OA8H
MAR*4%J?D%)E;BB</9 ]_4H++39*+/L049U0A"@=E/-5I5O3 2\QG80 .1%C0
M,;F!2. D@L!]#2W@K< KU>!_S2>Z$OM.5^Z(PI05 S(VGI<94 V\MN=H;XD$
MZJ::'H%@CYH#W3GLV9 @1=6N% ("S15OCR@UT,LIC#_AM9D,?RR J/;9^G O
MR>"7P+">::O[J+$1!<C;B<QA+\J+'W^ UG[22ZH69*<5<,0K?1WIOP=GD<-9
MM#@XBP[.HB_I+!H%J^4XG,Q&D;^:!J/9:K$8S\?A<K@*9326PX.SZ)#HOJNS
M:#&\;2H[@RL!AWL%3^=9XO+ML+*F6:)M)G89A)V6XT8,<,O/\90=1ZBZ$1"1
MTS<@R.E&+A]M"VA;-_N JH37V9K!4W MN=:AZ6W"/I2KY:&\&GW'=:>S^<U[
M+QY#S6D71'TX.G^CZM3X8[>POMJ:!*<#;O%%TZK$P!?>T>FQ1W*9E"G<Z*6Y
MT5E/HNH6APJI_R^/O=')C+)*&5.M\?Q'6&0XM4K)LSP1PDNJ]89&I:A,$7\N
MX=K/AVQR;)*8]EEVW.07?;+QET(O^A,<XQW/\8XGV++S;B%V%!U:!S2P:3Y+
M9'*M='0$/*SR389\3#G6VF8RY1Q35'@MA>(SW8NQLR/O</R^P/%["#IJ\=^M
MAS#6!L3#MC_RME\^P*Y;4BHE#6Z0P(BDME**/&3PGBI56$KH>.$0?O[M&?LQ
MQ!4\JGQ9^*0F3DTO!VC8RE-)> R4G\DB<,J0!IW8G!J?26L2:@ &_X< I!.1
M*B](FV?&Z[4,$1T !\/6?30):&BH(Q/-1);RSC3(H(BH.^0U(^RFYIPPH"I.
MUTI4M^RDS_!]=M"FH8)O\"5^<([V?LOPBG*]$44L9QT-ADW]V+X*+:(W</44
MC69XBZZPX "S8'B$G-Q]-.4R"SYYV88'5Z.(80B53MH5NI^F7'4!] '14-E)
M,QH;@2HWOIA<KF%EB'E(#CIIS>\==0S*C: :K3M0E(.M]:%MK<N#K?5/;&M]
MN.I#CY%O?,L*0UOK"WT;6<G+Q\A*?IBA_UCM:2I]!4,#ON.]QB)CS'?-Y"LK
MX?B06GP+3X@(QM-E%$7+U6@QG?IR*<0P&LMQ(,8K(2+_X DYI!9O(<$[I1:K
MHJ[[)O;:\%@LRJ+,ZS)R>]I 0CUIJPA*MKO5A*U11A'9X/FC0A@<-.A[-3][
M=[.88'!<7!2JQ$=3<\VB 2N-81R4:RNUI7XD0F\/VJ:%%\DD8_0^M"T3 EU<
MA!*-=-3(999<HBJUSG+4PJI\$Y=5* =>B,Z44G5%T9]9"D]$N:A NU4'O1[$
M0!]W%=G#SC@T&Q8#,@ER4&A'BZX;0".DS_R*?'D7($N34ZN!6)AG@0RQ_H?M
MR5,A0YAI$&.4J@E",@&[IFUHS2J<Q#V1JIY+1!JFYDACSZ*(,*/C@H(?CP\6
MR:_#(.[=UA;>);V@Q16%E\IS&+PD8&@,-XNJ!.\(6E<J+K22RXT4I8*M1&71
MSJVT#TXC1K*%DGDX/U_0HGU'<MP].A6G$(HDR"ZRA(ADDLAS)#UY=5ZP3PX&
MEG*T8NG%<"KBO.@$/?8Z"C.[LH #X.YPGKZ<J?R^CA-(DB  IN?BG!'3+;+#
MEF)*M2!X^NM&MD4&,OG HRH- V#Q<#I$HFJR2BSYBND8P/(H#1=YZ%66?]HD
M(L ><U#"F.'6N3ZZD$(2K^.2LQ\*^1GMLO;S*N"=LI#B;?6]NH/7%14W&<S!
MQ-MWL85%F&U*7::0 U5<8_<ZPSA<AT>_#@_A.'+30KXB.M%'7Y$Z(+N^4)_2
M[*IH"'FHM%%V#WDJ\/M4I?NP\&>?0SAUZM32H=WEFAW.W>.?NWX_]?T=.1$P
MZT6H5:6*%59IP+:T%Y%U#05$T*= EKP>>+Y(/^75IL3?,?D?2!6F/$= L-(
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MB1V3&!6JBI3ZTJI3BOC==+LN19S0 . 8K*544PM 2B]DHNJ)(G@UR5 H#65
MF*ZY  @&/9$<DN& &+H77J>@I=ZSV+U#>.PK#$IE<",XBS'AZ2)Q<9,!B@$>
M[$ 0&)F3KWA]KZW+OML5;^\&2W^7H'9HFD:E,R]CH(3JSJNREZH,)GY/93$U
M(!\2/E&5%UD>*R!N+0'UM<NWM6A<UQXR<']WF ^N14::*>O6*FDR&J_]*N^
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MFSPM5\_8'?MOXDAZ'X)8IEB4C/PW:7 R\(3W6B:8&(,);IBFH3.!&Q"^JBP
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M78.[WGV@._(<7>ESW![[XRS9>-=^=RU$_@15G-OH+@>1["F(9'>4Y&]_!]4
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M9]IZ(-K.XQ%_@['?'_B#WC#J#OVI/_,'8Q$->MVH-YC)L/?]BK_Y$Q%_IV"
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M\'*WK';GM:W3\U33G7MH\B*[0N28:9'KAG.@F:+(_(G%+0N;$Q/=8<&<0]\
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MN)7G*_B"G.!P2RNC[U+!YD$[DM[![)#K>:D*9 W$\FMGPG,#W6KK&&?&ROQ
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MF.Y)8-RN.//V8F.-5_-+!U.=*5)?1W;L"L[:E;'@%2?5PZ9_!;_.L^2X1E?
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M,C5U6V_: \<Z;:K==2S:X>AXHY=- )>%N&!_/R7LB4_25,@AJ(79,JYY@.W
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MK&]]\TE>T^4MY^Q6\[3&16?OF/NY!+9ZT2WS1IRS^DUN'CX;"I,19$MR"!R
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ME1O&:9\Q15X@Z%+0,V_?W/4)P!^K.O5Z :I"=&OF?PPSO[E#UHB4X' Q"O%
M2U.Y0/E:'"Z71R $^H]?"&A#'^M5-2]O?<(M'@YUOD&%[:@M1/7LFW0*K*S6
ME()F^G_]5C%I^H5-/H%\?2O<K$Q" 8JJ+J%1(S/)KAJ*:JLN:(MH2VE-89Q+
M5H[0NJ6_:\HI5YVO-#E+'U?Z&Z=4@DZ8:]<),L(16S H;A)K9W+#5$:3E<B+
M+ GI&U@&,:>_6*.6](XYUP2)4]0;Z3%1ELB0@Q1X<-1S:1JP&'KXAU9?=6%)
M,%O %JD/'S]K/0S6QRJG9LM\!1JKI+XKRA0CM>J3 ZL62O9[J!\H+XCM+E'S
M6"!!>W&_>J>RAS8X$,RFZ#B5HL:VN$+*,:+;P2YGYE^*,AW9SEIJE9GTD*Q$
MD2JS!NO1E&87&2NNGH&+_X;)Y8$J.HM"DPSRFJK]8,WA[F=/ZUV\/_$"UH92
MT>;FJ<Q,-.4L^A53 1GI5ZK2-!W+=E2%,\A\4;S45!:GH%1E^B6IMM+B+K2L
M:VU0P\Y;E; [JF-.CP9BQ;)*,;W81(W\=JR+4^CE^A0CU8GFSE,2!J89B9)2
M+@=&?S9.1[&BR92J8ICY9\=ENR^SHD#.'FV^N\UU96J3:4R_ *U9GZN@I U
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M3?^&RZDI\N+* S0GRG4O#BG4<HW""/8.?55I:QAFRQ%#2@JIP#B=%J@<7>E
M]PD4@WHJ7AO&QU4-4'_WZ/?^_$'N?2YA%2F1DV0%(2X+O'HH&M)V<JH:)(YC
M8NK79)>J%@4BG5 5PK"IJI2DXF?BLP<VD2A-J8,J>*.8XJF<G(1[E4CNK4@X
M@IY5%;,6=.K1[Y*+![E+-DO(UD56US+P#_K$8%Z<LE-C_+3Z17\0;)2K_%I0
M-E%493=T $;%7V_$:!Y48K+M ^<F3($BI8O_*JX.2=E\[)LK?@R;BV21AEW8
MI9*:IF?(17F^*I1I5R_MLY^<$![:9QHOW4B'B!&($]3+-/%968"IA+]A>#_%
M_>%K!4!0E3JX4".<(+BA29DTJ.Q"'Q$=JE??A JO44VOU>6JLE$+/H^GT,?D
M(1%>QI@9DC%T _I/$Q2+O J$UBL T?FGYBB.KZJ9U"8%?J4@ B81H#JXN$7D
M9X$CM4\K6_*OLE!6)0I'P[Y"]BJ!<J^ UR<<*.KO T7[0-&3#Q35JN7<-OWA
MQ/OE]-WIQY-?O8^GOYZ>G)UZK]\CB_K[<^_T'^>G[UY[Y^^]5[^^/?GMS#O_
MV\DYIDIXKSZ>OGY[_OZC!__'C[U]]XOWX>3C^3^KQ__SW?L_\ =GOY]].'UU
MCNV<_N/MV;GW]IWWM[=G^-7?3C]Z;T[^#G^IAL_?_G;JO7]C70?,G *MX]>Z
MBR?8+>A,QWO[AM[SSOOYG]#H;ZK1CO?'^]]_?>W][>3OI]YO)^>G']^>_/KK
M/[V3-V^@)Z>O[?>?G9Z?_WKZV^F[<RS \3=ZS^O3GVNC@R=H<%\XG^4.%SP"
M/ZD^)26M(FY#Q*BCA%)?Z!U'I3J\P=GW[,A,([0VF?@=3&^JL!-45O=*8JG(
MPL))L'&E7);L?=0E;:OU7.9PD\;+1(%+0/E-X*IFI0*+HL5&-?#"3"$/]0=*
M1Z.[.Q"IJDRM-0E605B_4/?\C=[Z#2B9G)S<A/.+458:[QEUW(*"L ?%>%T5
M)'&.9BB%E.!75#N\GA#'KHMU</FZQD(*&-7&Q?C@*IF+ROFB=8U^[XTV8LXJ
M*,OIY^!"I'-9N<0'0^RO?FK:'9NG-KBQ,WN!09\IRD3Z2795^4K:A19=J)G:
M#%ASIKWBUN23\4T5]ZC*7D3Q1ZJZ7;TKI!HXU2;=L)I(9( **@>1=?;B$G-"
M,0Y42JX>J+Y7.'(.DEA!C/=+W!.K%%<.;#T%YFS,#WGN[6"3FH!JY(T"JWX6
MDLE8;1F]86BGPXD0*[ 5<TZ&KNH2XEM52]HE:*5OVHY\5XYIU/(+>@=F_]&$
M&M!]7?>N)K?2EM7)5-F9OLAM@4)01EA1'!XT5\T#55\$"2%+A&VA$T]&KC12
MFER-JC7N(A!><BY#>Q 9-&,<.X<=VZA;I99+%.T4F18F3%(YO*UH+^'BZ5B:
M(&2]GJ/.:LFB-;@R+:\R4RG5R@:M]IX*EJF*]@U G9EM5!*7=73_FOZTTXE>
MO?_YXXG='QRP;HHD$6=>%#KK51$*A"J]V\KR=4+A[;UF]^D*Q%")E9_-/&%^
M>"N<9P_*@2=L^%!JF86-D]Y"^:'0T=*E@8ZO$MFL.T=7SUQW]^!6JA ?]2RI
M?->LM:^>'7MG)\[@\6<^G1BO@O;^_L$524TJE-I%)Z]/3S9F155"4N5Z;/!7
MP!9#G4M7$.==Q?^ZWJ""Z1+-NP78[T#?4A^S3JKIJ&"W+A6O:KA6(Z$!XNCU
M '5IZ^LMIJWFF7*W;HYCK?I\E>=O:X8X>>@C;KB%K:F$05HEJ[=(H;C-VG/=
M;CO9;0X/ZDKU:R<QKC)*U3"9^  9"42RXL+ #9?T%6J^*M542?.V7XV,J>I.
M5G)NESW<\KF1FH0C06U3Z0F*'=P[$(?VI%YDJX1N)8J<*/8<XVE%JR"C["&%
M9Z#&:J$5#R1JHR_]'JS=-<-=C*.>+UN:=6JB/@$6P8O6(#NZMKM*\U&L,/ )
M2X?V56/=AA@+@'N<KC9U0^<R7)EZU*2H(3["IJ-!=^OU483#.!B.#K<81-5O
M<Q2M O!5H6=2J##U&1%Q<::(,2YC>56?!B=5CC*G*'TYI*RC3.=V8>B7 ZGQ
MPOR++8NB7=L:UBIHKA4F?Z<5X(^&S"0 N-:;. O:-=MY4-DGV?S"I7HP_$0I
M2/594"H&=#<\W#PEAM%&I6$9V6$1*:@9Q\&"G1WG".?$I3J0AX:]I%6E'</>
MESH3&_Y6-;$;NG. G9'I7 4QL3XYR5DOE W\JP4[57H'"(TXI.AVY-@#2@;5
M92-B=I0&!$I9O  3F'E5C%))794AZWLR%0EN1,[4PZ (VQ:4[EMD&&9/<,WK
M1<XKB\:_MDU$+6K?VL=PLW16(K1<Y2GUN!&,@VFA]U/69&L3@! Y@-ZJ<ZA7
MD:$%48RJL)^A=Z7-97&#I(R@=PH\IB]#!),%%S";::V\>^W$PNQD):K@D8)O
MH1!HR\/'GD(_?/R*)/-HL+'HT!-K&YCV!Y6JUSX2;782DK+"JE;?,U6"L4Y7
M^:52'\VV)^X5P1>0^K4O$0E)TB1&1@?0BW(^8AB<6_%-1=8O<53\N0(]*8P-
MVE;D?LQYX;A!_<91B='@1M<&V-+L@F!G($++LIC29!TR5)N^)JN?G1=X+E0H
M44?"R6-9FR!K<LSGCWWGCQ[_SG^7>>]17/^6A08UZV2(J6T'U,NS-+FFD#+C
M8=GIIM5'E.TMO WJI%SVVKHR%,E"PU?P!7?&$PZU#O:AUGVH]<F'6K_ 13!^
M_!?!+Q2Q0-G]J[AZB?XI0F!^1&K-U7:W@D$9-9BQZL$D@ZCITXU@_CE!-P-9
M6?.--%6/76F8//Z]<FJ,:&2XW^A87><P8+O[!F.P\@[$I?*5U+Y7U*&4,509
M]@I]B29@O$#.4.AC<FVY*#2#75I>J/[:?6MVK4$LPXI-DY:ER+PD0XV>K%;C
M7:O4H)J7)V7? KLD9*H&V5"7?(DI16QNH%_SL>_[Z>/?]W_7GG"]3&S/N(C2
M=_.55[]B9UEKA]E^AXIS@Z#R*TH]IK!H2*99E*PHE5>= W9JYA8-EB,B"V_+
M0_JI:K[I8))L\''>,#9BA3V8WJWM^-,@[YM9D3G:;LB6'*QU30^-VS>-IPI]
MYUMXG%5 ,+:]H_64Z<* QRF>6I\137YO#XH] [FDMFLNLC8R=Z.'50D%U1FV
MK?@B->[J#B9-9Z7.VB,3?(.?%7I*!C]Z#M)"KEDP LE>9#$#$LC]F7#R#).&
MU:<@IQALO5UVP+HW?2NJ7<A_K9BMO]UAXFZ+;"0O25;T0.!N>DF^V%I,#O?G
M=869PB>Y:\1,&C/\0;DIVND>K'E$S94  \9R*S8RVO$>,U[YA^74NP7\[.T[
MQ,R].ST[\XA[_OV;.MDZQ3O6B2<E:RQ6O) "_-7&)X[SNT?)'V'U9R\.__KL
MWX$_$-/A,(I&8C:<#2=^;S")HDE_-AV+T70:[58DVI0J&I@1WG<%I-V:;=ES
M=P='?HVZ>_8\.DH^N09_^TJPHS65H[:JWWA3Z[WUK:_I[Y93U##VUU6_NH>*
MU7=6,=$:"5^L<7)MF-7Z$/MKZXGM6,-ZJY<-CV<[SNDVK6_J/CD[U_3=^4K/
MVL!?Y*37),DM"^K=//Q-0^O1T.YV4!Z<3+Z_JK /;FA?_KKAFE)OWYQZ9Z_>
MGKY[=7K&-:7>O3J^S054.2H;-?T>H4+S)325VO5[>Q%7U6BL-[CU!;MM%^V]
M^PT.FO-FN.\IW.(M=[RP?[Y^L9U3R#.7^JW'T_]AZPO\7B>2%+-;K]?WKJ3=
MM.QK0E-[#>]69]<UH7<\4O>PI>K^BZ/>Y+AG1>(Y)5)_N+L^^4XLY(M[4B%O
M/-)?1X5\U)<EL>J]N$L-Y/7R8KO:R/?UG#/H78<:_+1[7.(.^([A.GS')EB&
M"V=1MPG;8(OZ][6#*E9E9C[*N6G^C&7K"P]#<JL%4OK(!D"C^MOZ:SO%X'__
MKQ^?8_(=_7%1+A+XX_\#4$L#!!0    ( .DZ*EII<LNZDQ0  &1*   5
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MZR8V3J73 4<U9C%WWF@.1H@@N?.<!=R?(K&D7GJ14DI&W9@ Z7)#K.E9Q_L
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M:2TR,#(U,#$P-U]L86(N>&UL4$L! A0#%     @ Z3HJ6CB_$,'^!0  ZD
M !4              ( !9PP  &%T86DM,C R-3 Q,#=?<')E+GAM;%!+ 0(4
M Q0    ( .DZ*EI6!G")]1\  &2_   1              "  9@2  !E9C(P
M,#0P,# T7SAK+FAT;5!+ 0(4 Q0    ( .DZ*EHH2J_&8&T  -;? @ 5
M          "  ;PR  !E9C(P,#0P,# T7V5X,3 M,2YH=&U02P$"% ,4
M" #I.BI:]0'G.)-G  !XLP( %0              @ %/H   968R,# T,# P
M-%]E>#$P+3(N:'1M4$L! A0#%     @ Z3HJ6FERR[J3%   9$H  !4
M         ( !%0@! &5F,C P-# P,#1?97@Y.2TQ+FAT;5!+!08     !P '
+ ,T!  #;' $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>ef20040004_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="atai-20250107.xsd" xlink:type="simple"/>
    <context id="c20250107to20250107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840904</identifier>
        </entity>
        <period>
            <startDate>2025-01-07</startDate>
            <endDate>2025-01-07</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20250107to20250107"
      id="Fact_3860b181bf36435cbbfac6dc40cc9ac4">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20250107to20250107"
      id="Fact_6158d46d0163421d8adffc37bcbe83fc">0001840904</dei:EntityCentralIndexKey>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20250107to20250107"
      id="Fact_fb5876eac4474b3eaaeab0a3f3b2edb6">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:DocumentType
      contextRef="c20250107to20250107"
      id="Fact_d49699ee6bed43a2b007e3a2e70e9bf7">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20250107to20250107"
      id="Fact_53afa4ced35342c99f5e36b2e090ed85">2025-01-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20250107to20250107"
      id="Fact_05cb851f552e4dc38bf41f8c983c9ba5">ATAI LIFE SCIENCES N.V.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20250107to20250107"
      id="Fact_2811f0ce8b4243fd965af9d4691c810b">P7</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20250107to20250107"
      id="Fact_21197cf0332b45358cb2bc538b9bbeed">001-40493</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20250107to20250107"
      id="Fact_7e20ec09988745c8be237c1ef743c25c">Wallstra&#xdf;e 16</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="c20250107to20250107"
      id="Fact_58ccee47255d48d191446d52e3c7d180">10179</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="c20250107to20250107"
      id="Fact_02f10e87f08241b69628fcfd34a0b57e">Berlin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="c20250107to20250107"
      id="Fact_e018e901511b4557b39a3347a49f54d5">DE</dei:EntityAddressCountry>
    <dei:CityAreaCode
      contextRef="c20250107to20250107"
      id="Fact_b263dd54d1c4421a88eb80268a88e465">49</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20250107to20250107"
      id="Fact_e2dbb6ba344944729b6173600e671b0a">89 2153 9035</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20250107to20250107"
      id="Fact_e174097f5bb14b1fa914954aba9747e7">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20250107to20250107"
      id="Fact_60a92db11d8c425a9a5a5e77e3d26d34">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20250107to20250107"
      id="Fact_c4b7110b073b4f1bbd0f5fd028de128d">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20250107to20250107"
      id="Fact_b6339c49fd184e9c87be65baae816cee">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20250107to20250107"
      id="Fact_5f56ca7809a041818065c93ba9cb8d18">Common shares, &#x20ac;0.10 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20250107to20250107"
      id="Fact_0c5d8fc3c75c4379836d450a393644ea">ATAI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20250107to20250107"
      id="Fact_f8f9c5049f40477383f0c5e9f676c6e9">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20250107to20250107"
      id="Fact_483b590572924a1c9d10ba1d682d6427">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="c20250107to20250107"
      id="Fact_f865a07d406849fe91035d9a2e66a1ec">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
